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ABSTRACT

Bobinski, Thomas Paul. Purdue University, December 2013. Osmium Catalyzed
Dihydroxylation and Oxidative Cleavage of Vinyl Sulfone and Elucidation of the
Vinylsulfone Polypropionate Methodology for the Synthesis of the C32 des-Methyl C28C34 Actin Binding Tail of Aplyronine A. Major Professor: Philip L. Fuchs.

A general methodology for the generation of dipropionate functionalities
using cyclic 7-membered vinylsulfones has been devised for the purpose of
synthesizing polyketide natural products such as aplyronine A. Final oxidative
cleavage via ozonolysis has been shown to be difficult providing variable yields.
Furthermore, elegant synthesis of the C28-C34 segment of the aplyronine A actin
binding tail has proved elusive. Utilization of OsO4 and catalytic citric acid has led
to a methodology whereby harsh ozonolysis procedures can be mostly avoided.
A reengineering of the vinylsulfone polypropionate methodology in conjunction
with osmylation has been found to provide the actin binding tail under mild high
yielding conditions. These discoveries will be key in developing a methodology
for providing highly complex large scale substrates for the synthesis of
asymmetric natural products.
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CHAPTER 1: RATIONALE

1.1: Biological Basis for Total Synthesis of Aplyronine
Regulative intervention of the mitotic process is experiencing intense
study. The cytoskeleton must sustain a large number of chemically driven
changes to successfully divide. Success in cancer chemotherapy using paclitaxel
(Taxol™) to stabilize microtubules has elevated all three major polymeric
constituents of the cytoskeleton (microfilaments, microtubules, and intermediate
filaments) to be crucial targets for aggressive research. During cell division, the
microtubule cytoskeleton forms a spindle apparatus between two microtubuleorganizing centers, called centrosomes. During mitosis, chromosomes attach to
microtubules and subsequently move to the spindle poles. A multiprotein
complex called a kinetochore links chromosomes to microtubules and powers
poleward movements.10,11,17,18 During cytokinesis, the actin cytoskeleton and
myosin motor molecules generate a contractile ring that cleaves the cytoplasm,
forming two daughter cells. At the beginning of the 21st century the importance of
centrosome amplification, aneuploidy and chromosomal instability were often
heralded as causes for tumorigenic invasion and metastasis and are
unquestionable markers of unfavorable treatment outcome. These observations
strongly indicate the need for a more thorough understanding of the major
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biochemical events that lead to disregulation of the centrosome. While cancer
chemotherapy that targets DNA synthesis (with attendant interference of DNA
metabolism) often leads to drug-resistant cells and secondary tumors, a
treatment regime that effects regulation of the centrosome might eliminate
proliferating cells while avoiding the issue of chromosomal instability.17,22-27There
are similarities between DNA and centrosome duplication (initiated at G1,
regulated by many of the same protein complexes).28However, while the
mechanism of DNA replication is well known, understanding the detailed
operation of the centrosome is a subject of tremendous interest. Both the
microtubule and actin cytoskeleton are critical for proper cell division and are
affected during tumorigenesis. The actin cytoskeleton regulates a number of
cellular processes, including cytokinesis, cell migration, cell polarity, membrane
trafficking

and

apoptosis.

Monomeric

or

globular

(G)-actin

undergoes

polymerization into filamentous (F)-actin (Fig. 1.3 and 1.4)11,29-32 and represents
the building block for a number of different F-actin subpopulations such as the
contractile ring, filopodial bundles and lamellipodial networks. Actin organization
and dynamics are regulated by a large number of actin binding proteins (ABPs).16
Besides the microtubules, the actin cytoskeleton has become an interesting
target for anti-cancer therapeutics,33 since several actin-dependent processes
become out of control during tumorigenesis, including proper alignment of the
mitotic spindle.34 An actin-dependent cell cycle checkpoint at the G2/M transition
controls mitosis in primary mammalian cells, and the regulated polymerization of

3
a dendritic network of short filaments near the plasma membrane drives cell
migration in normal and metastatic cells.35-37
Various marine organisms such as sponges and nudibranchs as well as
fungi, algae and bacteria are known to produce natural products with high
specificity to the actin cytoskeleton,2,33,38,39 Several of these products, including
cytochalasin B and D, phalloidin, and latrunculin A, (Figure 1.1) have emerged as
essential tools for cell biologists to study the organization, dynamics and function
of the actin cytoskeleton. Since actin is involved in numerous cellular processes
that are affected during tumorigenesis, including cytokinesis, cell polarity, cell
migration and apoptosis, these agents are of potential interest as anticancer
drugs. Aplyronine A 1.6 is an exceptionally scarce macrolide originally isolated
from the sea hare Aplysia kurodai.7 It has actin binding and depolymerizing
properties3-5,7,40 as well as potent in vivo antitumor activity4,5 However, the
molecular and cellular mechanisms of how aplyronine A 1.6 mediates its actin
depolymerizing, anti-tumor and cytotoxic activities are poorly understood.

4

Figure 1.1: Chromophoric Bio-Visualization Substrates
COS7 cells were treated with 50µM -(-)Blebbistatin (A) (not shown), control
medium or 0.4µM Cytochalsin D (B) overnight. The cells were then fixed with 4%
PFA and stained with phalloidin-FITC (green) to visualize the actin cytoskeleton
and Hoechst (blue) for nuclei. Both Blebbistatin and Cytochalsin D caused
drastic changes to the actin cytoskeleton as was expected.
Scale bar = 70µm, 40X Images shown. Images courtesy of Genentech.
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reidispongolide A1,2 1.4, sphinxolide B 1.545,46 and aplyronine A3-5 1.6. A second
set includes the “double-tailed” bis-lactones rhizopodin 1.8,9-11 misakinolide A (=
bistheonellide A)12-15,19,40,47,48 1.9, and swinholide A20 1.10 that bind monomers
and sometimes sever filaments. Notably missing in this collection is the currently
unknown aplyronine A bis-lactone 1.11, an advanced target in this investigation
(Fig. 1.2).

Figure 1.2: Natural Product Inhibitors Of Actin Polymerization.
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Dimeric bis-lactones such as rhizopodin 1.8 sequester G-actin by forming
an irreversible 2:1 actin-substrate complex (Fig. 1.3),9-11 whereas monolactones
bind G-actin with 1:1 stoichiometry inhibiting polymerization and accelerating
depolymerization. It has also been inferred that aplyronine A 1.6 is able to sever
actin filaments (Fig. 1.4).40 In his 1996 study, Saito first postulated that
aplyronine A 1.6 and mycalolide A 1.2 form their 1:1 complexes with actin by
binding to the side chain.40 Understanding the interaction of actin with the above
agents at the molecular level has been substantially aided by Ivan Rayment who
has46,49 used drug•actin x-ray structures to provide an in silico model of actin with
many of the above macrocyclic mono-and bis-lactones.21 The most significant
general conclusion is that the binding of macrocyclic mono-lactones with a
stereorich side chain that terminates in an enamide or oxazolidine heavily
depends upon the side chain while accommodating the macrocyclic ring in a very
forgiving fashion. C2 symmetric bis-lactones bearing a pair of sidechains bind
two monomers in an antiparallel orientation; the macrocyclic ring serves as a
backbone that allows the sidechain arms to snugly embrace identical binding
sites on the individual actin units.
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Table 1.1: Natural Product Inhibitors of Actin Polymerization.
Inhibits
actin polym

Actin inhibitor mech

IC50

ILS**

refs

Reidispongiolide A 1.4 (Y)

50nM

30nM (HT29)

NA

1,2

Aplyronine A 1.6 (Y)

31M

0.4nM (HeLa)

545% P388

3-8

Rhizopodin 1.8 (Y)
Misakinolide A 1.9 (N)
Swinholide A* 1.10 (Y)

100nM
10nM
.4nM-1µM

Cap&Sever F-actin
G-actin binding
Sever F-actin (?),
1:1 complex G-actin
2:1 G-actin/1.8 complex
(+) dimer cap; no sever
Sequester dimer; sever

Drug
#
Y/N)

(X-ray

+Actin

5nM
NA
15nM (L1210)
140% P388
20nM (12 lines) 115% P388

9-11
12-16
19,20

*The swinholide 22-membered ring monomeric lactone is devoid of antitumor activity; **ILS =
Increase in lifespan (T/C) in cancer-bearing mice relative to untreated control; #actin-drug X-ray
modeled in silico as small molecule mimics of gelsolin.10,18

1.2: Retrosynthetic Analysis of Aplyronine Macrolactone Core
Aplyronine A is a 24-membered macrolactone with the lactone formed
between carbonyl C1 and C23-OH. It has 34 carbons in the main skeleton, bears
5 olefins, 7 chiral centers (1.6), and two -aminoesters on the 7-OH and 29-OH
groups. The stereocenters are comprised mainly of polypropionate, stereotetrads
(alternating methyl and hydroxyl groups). Those polypropionates are C7-C10,
C23-C26, and C29-C32 tetrads. The rest of the stereocenters include stereodiad
C17-C19, an isolated stereocenter at C13, and the two -aminoesters on
hydroxyls 7 and 29 (Figure 1.6). After disconnection of the two -aminoesters
and replacing them with the appropriate aplyronine A analog esters, target
molecule 1.7 is revealed as the desired aplyronine A core (Figure 1.6).
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Figure 1.5: Retrosynthetic Analysis Of Aplyronine Core

Disconnection of aplyronine A analog 1.7 reveals 3 major stereotetrads as the
potential aplyronine A precursors (Figure 1.7). The core lactone is formed via
Yamaguchi macrolactonization between C1 and C23-OH while the trans-olefin
between C4-C5 was formed via Horner-Wadsworth-Emmons (HWE) olefination.
The C11-C12 bond is formed between a primary iodide on C11 and the position to a C13 carbonyl. The C11-C12 connection was presumed to take place
via SN2 attack of C12 anion on C11, which will be followed by Corey-BakshiShibata (CBS) reduction of carbonyl C13 and subsequent methylation of the
resultant 13-OH group. The 14E olefin between C14-C15 was to be constructed
via

Massamune-Roush

(HWE)50

procedure.

20E

trans-olefin

could

be

constructed via Julia-Kocienski olefination. The C27-C28 bond was to be formed
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with a Julia-Kocienski or Wittig olefination followed by a Crabtree regioselective
hydrogenation directed by the C29-OH. Finally 33E olefin could be constructed
employing Wittig olefination followed by iodine-equilibration in order to obtain the
trans-olefin.

Figure 1.6: Aplyronine A Core Stereotetrads

The next level of synthetic specificity that must be addressed is the
construction of the stereotetrads in Figure 1.7. A convergent strategy leading to
the aplyronine core will require the use of tetrads i-iii. These stereotetrads require
differentiated termini. Each stereotetrad has two hydroxyl groups that also must
be set apart. C21-C27 fragment (ii) and C28-C34 fragment (iii) possess
enantiomeric stereotetrads offset by one carbon. The position of the red and
green stereotetrads on their respective backbones will be an important
component of this investigation.
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1.3: Polypropionate Generating Methodologies
The construction of polypropionates in organic synthesis has been a
challenge that has been met with a growing number of methodologies through
the years.51-53 The Fuchs group has sought to add to, and improve the utility and
scalability of polypropionate production.54

Figure 1.7: Polypropionate Methodologies

A key structural feature of polyketides in general, such as the macrolides
aplyronine A 1.6 or misakinolide A 1.9 are the polypropionate segments. They are

characterized by sequences of methyl- and hydroxy-bearing stereogenic centers,
enabling

large

numbers

of

possible

stereochemical

permutations.51
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Biosynthetically, these are derived by iterative condensations of propionyl
subunits and subsequent reduction of the derived -keto esters. Mimicking this
biosynthetic pathway, the aldol reaction presents the most important method
available for the stereocontrolled formation of propionates and many variants for
regio-, stereo-, and enantioselective carbon–carbon bond formation have been
reported.55-58 Furthermore, alternative strategies are of increasingly high
importance. To gain perspective as to the effectiveness of the vinylsulfone
methodology, a survey of well-established as well as more recently developed
methods for the stereoselective assembly of polypropionates is required,
including propionate aldol reactions,55 thiopyran reductions,59-61 crotylations,62-64
allenylations,65-67 allylsilane addition,68-72 silicon tethers,73 epoxide openings,74,75
rearrangements76,77 and Diels-Alder cycloaddition78-80 (Figure 1.7).

Figure 1.8: Aldol Condensation

The aldol addition reaction continues to be a highly versatile and widely
used method for selective polypropionate synthesis.55-57 The addition reaction
involves the condensation of ethyl ketones (1.12), esters, or amides with
aldehydes (1.13) to generate the required chiral -hydroxycarbonyl adducts
(1.14) in a direct fashion (Figure 1.8).
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Figure 1.9: Aldol Condensation (Evans)

The relative configuration of the aldol adduct is usually determined by the
geometry of the enolate intermediate, with Z-enolates (1.15) giving syn products
(1.21) and E-enolates (1.16) anti products (1.22). As shown in Figure 1.9, this
result

has

been

rationalized

by

Zimmerman–Traxler

transition

states.

Minimization of 1,3-diaxial interactions between R1 and R2 in the chair-like
transition states 1.17 versus 1.18 and 1.19 versus 1.20 leads to the observed
stereochemical outcome (Scheme 3).81
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Figure 1.10: Evans Oxazolidinone Auxiliary

One

of

the

most

widely

used

methods

of

auxiliary-controlled

diastereoselective aldol reactions employs the class of oxazolidinones58 (Figure
1.10), inititally developed by the Evans group for syn-aldol couplings.55 The synaldol adducts are typically isolated in high diastereoisomeric purity (>250:1 dr)
and yield. Enolization with dialkylboron triflates selectively affords Z-enolates
(1.30). The model proposed by Evans to account for the asymmetric induction of
these chiral oxazolidinones is presented in Figure 1.10. It is based on
minimization of carbonyl–carbonyl dipole interactions between the imide carbonyl
and the aldehyde. For aldehyde addition, the reactive form 1.25 of enolate 1.30
has to be considered and two diastereomeric conformations (1.26 and 1.27) of
the cyclic intermediate have to be taken into account. Due to steric interactions of
the ligands on the boron and the chiral auxiliary, transition state 1.26 is favored,
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consequently giving rise to ‘Evans syn’ product 1.28, as opposed to 1.29. Since
its inception many permutations of this methodology have been developed.82-88

Figure 1.11: Crotylation (Brown, Denmark, Roush, Corey)

Asymmetric crotylation reactions have been studied extensively and used
for the stereocontrolled assembly of polypropionates. One of the most intriguing
features of these reactions is the predictable relationship between the
configuration of the product and the geometry of the starting alkene. According to
Denmark’s analysis,89 they may be classified into three mechanistically distinct
types. Type I reactions proceed via a rigid chair-like transition state 1.31 (Figure
1.11) which is characterized by coordination of the carbonyl to the metal atom.
Consequently, the syn/anti diastereoselectivity of the product 1.33 reflects the
Z/E ratio of the starting olefin geometry. Boron reagents are the most prominent
representative of this type.63,90-93 Type II reagents (1.32), exemplified by
trialkylsilanes and stannanes usually proceed via an open transition state and
require Lewis acid activation.68-71,94-97 Type III reactants, not illustrated in Figure
1.11, also proceed via an open transition state. They provide the same
diastereomeric product, independent of the starting double bond configuration.
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Crotylation reactions may also be classified into stoichiometric and catalytic
variants. The most widely used stoichiometric crotylation reactions belong to type
I reactions, with Z-crotyl reagents giving syn isomers, and E-isomers the anti
products. This simple stereoselectivity may be readily explained by Zimmerman–
Traxler transition states.

Figure 1.12: Crotylboration (Brown)

Chiral borane reagents have been developed by Hoffmann, Brown, Roush
and others.63,91,98,99 Hoffmann and Zeiss have shown that the reaction of (E)- or
(Z)-crotylboronates with aldehydes results in the formation of anti- or synmethyl homoallylic alcohols,100 which may be explained by chairlike transitions
states. Use of crotyl(diisopinocampheyl) boranes 1.33 and 1.36 was developed
by Brown63,91 (Figure 1.12). Owing to the good performance and commercial
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availability of the chiral auxiliary, these have become the standard method for
asymmetric crotylation. The high stereospecificity of these reactions may be
explained by closed chair-like transition states 1.34 and 1.37, where the boron is
coordinated to the carbonyl oxygen. The aldehyde is oriented in such a manner
that the R group is placed in an equatorial position of the chair to minimize steric
interactions between the Ipc group on boron and the allyl unit.

Figure 1.13: Crotylsilane Mechanism

In general, the addition of allylic silanes to electrophiles has been
established to be a stepwise process.101 Thus, initial addition of an allylic silane
to an activated aldehyde forms a carbocation, which is stabilized by
hyperconjugative overlap with the carbon-silicon bond (Figure. 1.14). Cleavage of
the silyl electrofuge then provides the homoallylic alcohol product.
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Figure 1.14: Chiral Lewis Acid Crotylation

Chiral Lewis acids have been widely employed as catalysts in the addition
of crotyl organometallic reagents (1.39, Figure 1.14), mainly derived from Si, Sn
and B. Usually, these reactions may be classified as type II reactions and
predominantly the syn diastereomers 1.35 are obtained. Enantioselective Lewis
acid catalyzed additions have been reported by Yamamoto,102 Mikami,103
Nishiyama,104 Evans,105 and Hall.106,107
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Figure 1.15: Catalytic Cycle of Lewis Acid Catalyzed Crotylation

In a mechanistic investigation on the addition of allyltrimethylsilane to
aldehydes catalyzed by Lewis acids such as [Ti(Cp)2(OTf)2], Ph3C+OTf-, and
Ph3C+ClO4-, it was found that the reactive species is actually the electrofugal
trimethylsilyl cation.108 This possibility was first discussed and eliminated in the
Lewis acid-catalyzed aldol reaction with trialkylsilyl enolates.109,110 In the former
study,108 a trace amount of water in the reaction was shown to hydrolyze the
Lewis acid to generate a Brønsted acid. The Brønsted acid then reacts with
allyltrimethylsilane to produce Me3SiOTf or Me3Si-ClO4, both of which are
powerful catalysts for allylation. Furthermore, dehydration of the solvent or
addition of a hindered base to quench the acid does not necessarily prevent the
formation of these silyl catalysts. In the case of [Ti(Cp)2(OTf)2], upon activation of
the aldehyde and addition of ii, the metal alkoxide i and Me3SiOTf are produced
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(Figure 1.15). To achieve a catalytic process, the metal must dissociate from the
complex assisted by the silylation of the adduct. However, the silylation does not
occur, and instead Me3SiOTf functions as highly reactive catalyst for the
allylation. Thus, the reaction is actually a metal initiated, silyl cation-catalyzed
process.

Figure 1.16: Epoxide Opening (Posner, Lipshutz, Trost, Kishi, Miyashita)

Stereoselective epoxide-opening reactions have been recognized as an
important transformation in organic synthesis and are widely used as key steps in
natural product syntheses.111 Nucleophilic substitution reactions of trans or cisconfigured epoxy-ols 1.36 and 1.41 with organometallic reagents, including
organocuprates and organoaluminum complexes, provide an efficient method for
the stereoselective construction of propionate frameworks.111 Regioselective
openings with lithium dimethyl cuprate112 or trimethylaluminum and butyllithium113
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preferentially lead to 2-methyl-1,3-diols 1.38 and 1.40, while trimethylaluminum114
reacts at C3 to give the 3-methyl-1,2-diols 1.37 and 1.39 (Figure 1.16).

Figure 1.17: [2,3]-Wittig Rearrangement (Mikami and Nakai)

[2,3]-Sigmatropic rearrangements constitute a versatile type of bond
reorganization with many applications in organic synthesis. This reaction may be
generalized as shown in Figure 1.17 for structures 1.42 and 1.43. It is defined as
a thermal isomerization that proceeds through a six-electron, five-membered
cyclic transition state.76,77 Mikami and Nakai have studied the diastereoselectivity
of a broad range of [2,3]-Wittig rearrangements and proposed transition states
1.45, 1.46, 1.49 and 1.50 to explain the results (Figure 1.17). In general, Econfigured substrates (1.44) give anti products (1.47) while the Z-congeners
(1.51) give syn isomers (1.48). This may be explained in terms of pseudo-1,3-
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diaxial interactions of R with H in 1.46 and 1.49. Accordingly, 1.50 should be
sterically favored, thus leading to syn-selectivity. The order of selectivity is
correlated with an increase in 1,3-repulsion. A marked dependence of the antiselectivity on the size of the substituent R is best explained by additional steric
gauche interactions between R and Me in the preferred transition state 1.45,
hence the anti selectivity decreases with an increase of this gauche interaction.77

Figure 1.18: Wittig Rearrangement

Application of the [2,3]-Wittig rearrangement reactions of (Z)-allylic ether
1.52, a cyclohexanecarboxaldehyde-derived intermediate for the synthesis of syn
stereodiad 1.53, was described by Parker (Figure 1.18 ).115,116 This product was
converted into (syn,anti)-polypropionate building blocks.115
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Figure 1.19: Silicon Tether (Phillips)

Silacyclopropanes such as 1.56 are strained silanes that undergo carbon–
carbon bond-forming reactions with various carbonyl compounds.117 Carbonyl
insertions proceed with high stereo-, regio-, and chemoselectivity to afford
oxasilacyclopentane adducts (1.57) under mild, metal catalyzed conditions
(Figure 1.20 ).118 Woerpel has developed a silver-catalyzed silylene transfer as a
mild and efficient method for the synthesis of silacyclopropanes 1.56;117-123 the
process

uses

a

stereospecific

silylene

transfer

from

cyclohexene

silacyclopropane 1.55 to alkene 1.54 (Figure 1.1). Treatment of intermediate 1.56
in situ with N-methyl-N-benzylformamide and catalytic amounts of copper iodide
resulted in an N,O-acetal, which may be hydrolyzed and acetylated to provide
oxasilacyclopentane 1.57 in high yield. Nucleophilic substitution with silyl enol
ether 1.58 produced ketone 1.59 in high yield and diastereoselectivity. Wittig
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methylenation followed by carbon–silicon bond oxidation afforded diol 1.60, a key
fragment for the synthesis of 1‘-epi-stegobinone.124

Figure 1.20: Diels-Alder (Danishefsky)

The cycloaddition of Danishefsky's diene to aldehydes corresponds to an
aldol addition. The Cram product 1.63 (Figure 1.20) was formed with a normal
diastereoselectivity of 4.3 : 1 and, after refunctionalization, gave the carboxylic
acid 1.64 (stereotriad C).80 Upon changing the solvent stereotriad A could be
obtained with a selectivity of up to 10 : 1.78,80 It remains to be clarified whether or
not high diastereoselectivities can be generally obtained with reagent 1.61 on
addition to chiral aldehydes.
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Figure 1.21: Thiopyran Reduction (Fujisawa)

One of the most intriguing non-traditional methodologies for obtaining
polypropionates is by way of thiopyrans. An exhaustive review by Ward59
elucidates the flexibility of this methodology. By way of example Fujisawa et al.125
employed enantioselective reduction of 1.66 as the key step in a synthesis of
sitophilure (1.68), an aggregation pheromone of Sitophilus weevils (Figure
1.21).126 The preparation of 1.66 involved alkylation of 1.64 with 1.65 followed by
intramolecular Claisen reaction to yield the 1,3-diketone 1.66 in moderate yield.
Baker’s yeast reduction of 1.66 gave 1.67 with excellent stereoselectivity.
Although the reaction was not completely regioselective, the ketol products
resulting from reduction of the exocyclic ketone were lost during the work up,
presumably due to decomposition via a retro-aldol reaction. Raney™ nickel
desulfurization of 1.67 gave sitophilure (1.68) in moderate yield.
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The goal of this project is to better characterize the effects of aplyronine A
1.6 on both the actin cytoskeleton and other potential cellular targets. In pursuit
of this goal, a greater understanding of the vinylsulfone polypropionate strategy is
sought. This knowledge is essential for potential future application of aplyronine
A-type compounds as anticancer drugs. Since the proposed experiments would
require unobtainable amounts of Aplysia in order to purify significant quantities of
aplyronine A 1.6 it was decided to synthesize a highly similar aplyronine analog
1.7, mono-lactone and bis-lactone aplyronine A analog 1.11 which is intended for
use in collaborative biochemical and cellular studies. (Figure 1.2)
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CHAPTER 2: THE VINYL SULFONE MOIETY AS A POLYPROPIONATE
FACILITATOR

2.1: Use of Carbocyclic Scaffold in the Vinylsulfone Polypropionate Strategy
Work accomplished by Saddler and Donaldson in the Fuchs group1
utilized application of the vinylsulfone moiety as a facilitator of asymmetry in the
total synthesis of I-(-)-Prostaglandin E2 (Scheme 2.1). I-(-)Prostaglandin E2 has a
-hydroxy cyclopentanone core containing three contiguous chiral centers
consisting of a cis-fatty acid, trans-allyl alcohol, and the keto-cyclopentanol.
Treatment of the racemic cyclopentene epoxide (2.1) with thiophenol yields 2.2 &
2.3. Racemic sulfide alcohols (2.2 & 2.3) were resolved on the mole scale by
treatment with 1 equivalent of S-(-)-(-methylbenzyl)isocyanate (2.4) to give a
mixture of diastereomeric urethanes 2.5 and 2.6. Crystallization of this mixture
from methanol gives pure 2.5. Cleavage of urethane 2.5 with trichlorosilane
allows for greater than 90% recovery of chiral 2.4 for recycle. The resulting silyl
ether 2.6 is then hydrolyzed (without isolation) with dilute aqueous hydrofluoric
acid to optically active sulfide 2.2 (92% ee). Reaction of 2.2 with 2 equivalents of
peracetic acid gives hydroxysulfone (not shown), which is generally not purified,
but directly treated with 1.1 equivalents of m-chloroperoxybenzoic acid (MCPBA)
to produce highly crystalline epoxysulfone (2.7) 88%, 97% de. On small scale it
was convenient to simply use 3 equivalents of MCPBA to directly obtain
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epoxysulfone (2.7) (97% de). Purification of the mother liquors (plug on silica gel)
afforded 3% of the relatively unstable epoxy sulfone diastereomer epi-2.7.
Treatment of epoxysulfone (2.7) with catalytic DBU (to produce the dihydroxy
vinylsulfone 2.8) followed by in situ silylation of less hindered alcohol with tBuMe2SiCl and imidazole in THF; (use of less bulky chlorosilanes, e.g., iPrMe2SiCl, gives no selectivity between C-9 and C-11) gives crystalline monosilyl
ether, (79%).
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Scheme 2.1: Prostaglandin-E2 Via Vinylsulfone Polypropionate Strategy

Purification of the mother liquors gives 9% disilyl ether which can be
hydrolyzed to diol 2.8 (CF3CO2H, THF, H2O) in near quantitative yield and
recycled in the silylation step. Treatment of 2.8 with mesylchloride and
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triethylamine in methylene chloride results in the formation of the sensitive
mesylate (94%), which is not routinely isolated but rather treated directly with
dimethylamine at -20 ⁰C (<5min) to give amino vinylsulfone (95%). An expedient
preparation of 2.9 from aminovinylsulfone involves quaternization of the amine
with methylfluorosulfonate (1.1 equivalents, CH2Cl2, 25 ⁰C, 2 h) to give the
crystalline ammonium salt 2.9, which is not normally isolated but rather directly
treated with dimethylamine at -20 ⁰C (5 min) to give 2.10 (95%). Treatment of
amino vinyl sulfone 2.10 with optically active vinyllithium reagent 2.11
(THF/hexane, -60 ⁰C; the reaction is slow below -70 ⁰C) followed by quenching
with water provides a separable 92%:5% mixture of the cis : trans adducts 2.13
and

epi-2.13

(not

shown).

The

treatment

of

2.13

with

2,2,2-

trichloroethylchloroformate (2 equivalents, neat, 25 ⁰C, 72 h) in the presence of
solid sodium bicarbonate to give urethane (96%) as an oil after excess 2,2,2trichloroethylchloroformate, is removed with a silica gel plug. Treatment of
urethane with activated zinc in THF at reflux for 6 h affords a 92% yield of
desired secondary amine. These reactions have been easily run on ~40g scale.
Ester hydrolysis of with sodium hydroxide (3 equivalents) in 2% aqueous
methanol (48 h) yields the carboxylic acid (99%), which is oxidized with 40%
peracetic acid (6 equivalents) in wet methanol containing solid sodium carbonate
(15 equivalents) and a catalytic amount of sodium tungstate (0.1 equivalent) to
deliver oxime (2.14). Desulfonylation of oximino acid 2.14 is accomplished by
treatment with sodium methoxide and sodium borohydride in methanol to give
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91% of the oxime. Hydrolysis of this oxime (boron trifluoride, paraformaldehyde,
aqueous acetone) furnishes l-(-)-PGE2 (83%).
The I-(-)-PGE2 was obtained as an oil (6.69 g, 80%) after column
chromatography on silica gel to remove a small amount of PGA2. The efficacy of
the cyclic 5-membered vinylsulfone is demonstrated in Scheme 2.1.2-5
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Figure 2.1: Apoptolidine

A utilization of the six membered vinylsulfone by Chen, Y.; Evarts, J. B.,
Jr. & Torres, E. was employed in efforts to assemble the C21-C26 fragment of
Apoptolidine (Figure 2.1). Starting from dienylsulfone (2.15) Jacobsen
asymmetric epoxidation yields the enantiopure epoxide 2.16 (94%). Addition of
1.1 equiv of LiHMDS to the epoxy vinylsulfone to furnish oxido diene 2.17
followed by 2.5 equiv of MeLi generates dianion 2.18. Further addition of (PhS)2
results in regiospecific capture of the allyl sulfonyl anion to produce vinyl sulfide
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2.20 (isolated as the alcohol) in 82% yield after stirring for 8 h at 25 °C. As has
been shown in the 7-membered ring series, formation of intermediate 2.19
proceeds via conjugate addition of methyllithium followed by -sulfenylation. The
unusual -regiochemistry of this process appears to result from the interplay of
the weak sulfenylation reagent in concert with the high steric demand imposed by
the proximally methylated R-sulfonyl center. TMS triflate-promoted, lone-pair
assisted elimination of the crude diastereomeric mixture 2.19 and 2.20 to dienyl
sulfide 2.22 was readily accomplished in 94% yield by heating 2.21 with 5.0
equivalents of TMSOTf

Scheme 2.2: Apoptolidine C21-C26 Via Vinylsulfone Polypropionate Strategy
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and 6.0 equivalents of Et3N in methylene chloride at reflux for 4 h. The reaction
mixture was cooled to 0 °C, and 2.5 equivalents of m-CPBA was added in
portions; the mixture was stirred for 6 h at 25 °C to afford dienylsulfone 2.23
(Scheme 2.2).
Directed catalytic epoxidation of alcohol 2.23 with Mo(CO)6 (5 mol %) and
TBHP in benzene at reflux for 1 h smoothly gave 2.24 as a single diastereomer in
94% yield. Treatment of alcohol 2.24 with trimethylaluminum in the presence of a
catalytic amount of methylcopper affords 2.25 in 91% yield. The nucleophilic
methylation reaction has the potential of both 1,2- and 1,4-addition modes. In this
instance, any competitive 1,2-trans-addition results in formation of the
enantiomer of 2.25, an especially serious consequence. Fortunately, chiral HPLC
demonstrates that the enantiomeric excess of 2.25 is >98%, which indicates a
1,4-/1,2-selectivity ratio of >49:1 in the methylation process. The allylic hydroxyl
of diol 2.25 can be selectively inverted using the Mitsunobu reaction to give 2.26
in 95% yield.
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Scheme 2.3: C21- C26 Apoptolidine Fragment Assembly

Sequential treatment of 2.26 with excess tert-butyldimethylsilyl chloride, followed
by cleavage of the less hindered silyl ether with 1 equivalent of TBAF delivers
2.27 in 84% yield. Finally, ozonolysis of 2.27 in methylene chloride gives
aldehyde 2.28. For long-term storage, 2.28 is reduced with LiAlH(O-t-Bu)3 to
afford alcohol 2.29 in 50% overall yield from 2.28 (Scheme 2.3).
With the previous exploration of the synthetic utility of the 5 and 6membered vinylsulfone rings having been suitably illustrated, the strategic
implications of this moiety will be addressed in the following sections. Much of
the chemistry discussed up to this point applies to the 5, 6 and 7- membered
dienylsulfone rings. In the following examination, the chemistry that applies to the
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cycloheptadienyl sulfone ring, a key Aplyronine A intermediate, will be
highlighted.

2.2: Dienylsulfone Asymmetry

The implicit asymmetry of the vinylsulfone functional group contributes
greatly to its ability to facilitate asymmetric epoxidation adjacent olefinic
stereocenters.6-8 As is shown in Figure 2.2 the interaction between the adjacent
Z-olefin of the dienylsulfone ring and the salen ligand defines alignment of the
sulfone moiety and the equatorial side of the salen ligand, where the catalyst and
substrate interact in an exo-manner. Such steric interactions allow the oxygen to
be delivered selectively to only one side of the olefin adjacent to the vinylsulfone
moiety (Figure 2.2).
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2.3: Epoxide Directed Asymmetry

The enantiopure epoxyvinylsulfone (2.30) has directs further asymmetry
on the molecule via the Lawton strategy.9 The basicity of the epoxide oxygen
allows for coordination with Lewis acidic metals bearing nucleophiles to be either
delivered to the vinylsulfone in a syn manner (2.31), or directly to the epoxide in
anti fashion. As can be seen in Figure 2.3 the Grignard reagent coordinates to
the epoxide, forcing addition to the vinylsulfone cis to the epoxide (2.31). The
strong inductive property of the sulfone in combination with the ability of the
epoxide to be cleaved by olefin activation yields two chiral centers proximal to the
vinylsulfone (2.32). 10-12
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Figure 2.4: Syn Nucleophilic Addition to Epoxyvinylsulfones

The Lawton strategy can be used in an iterant manner to assemble the
syn-diad. As can be seen in Figure 2.4 the pyrazole N-H coordinates with the
epoxide, facilitating cis addition to the epoxy vinylsulfone (2.33). With the syn
motif established between the alcohol and the 3,5-dimethylpyrazole moieties, the
Lewis acidic coordinated Grignard reagent directs syn Sn2’ addition (2.34) to
deliver the syn diad (2.35).
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2.4: Aluminoxane as a Nucleophilic Methylation Species

Trimethylaluminoxane (Figure 2.5 is a sterically hindered aggregated
species with the ability to activate carbonyls and epoxides via a bidendate
coordination of two aluminum atoms to the oxygen (2.36).13 Maruoka and
coworkers showed that the methyl cleaves the epoxide proximal to the olefin on
,-epoxy acrylates. A methyl nucleophile from either a second equivalent of
aluminoxane or the aggregate associated with the epoxide then undergoes
addition to the activated epoxide in an anti-manner to deliver the anti-diad (2.37).
(Figure 2.6)
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Figure 2.6: Epoxide Directed Methylation via Aluminoxane Species

2.5: Differentiation of Termini Post Oxidative Cleavage

Figure 2.7: Cleavage of Vinylsulfone via Ozonolysis

The sulfone moiety also differentiates the two terminal carbons upon
oxidative cleavage of the vinylsulfone. Addition across the vinyl sulfone olefin by
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the nucleophilic ozone forms the highly reactive molzonide (2.39). Decomposition
of the molzonide (2.39) delivers a species with an acylsulfone end and a carbonyl
oxide terminus (2.40). Alcohol attacks the acylsulfone to form the terminal ester
(2.43). The additional advantage of this methodology is that the sulfone is
disposed of in the oxidative process, as very few desirable biologically active
target molecules possess the sulfone functionality (Figure 2.7).

2.6: Formation of the , -Unsaturated Sulfone

Due to vinylogy, the -position of the sulfone is highly acidic and when
treated with base (2.44) easily forms the allyl anion (2.45). The allyl anion when
quenched with a proton source yields allylsulfone (2.47). This reactive property of
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the vinylsulfone can be used with great utility to form the electron rich vinylsulfide
(2.46) from quenching the anion with diphenyl disulfide. The vinylsulfide formed
will be the platform from which greater intricacy can be introduced (Figure 2.8).

2.7: 1,4-Elimination of Sulfone with Trimethylaluminum

Figure 2.9: 1,4- Elimination of Sulfinic Acid with AlMe3

Sulfenylation product (2.46), has the perfect electronic motif for activation
of the sulfone by a Lewis acid and subsequent elimination of sulfinic acid. The
desulfonylation takes place through binding of trimethylaluminum to the sulfone
oxygen(s), and the free –OH groups (if present) to create aluminate complex
(2.48). Subsequent elimination of trimethylaluminumsulfinate occurs with the aid
of the Hünig’s base in a vinylogous E2 elimination (2.49). Alternatively, the
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weakening of the C-S bond leads to complete expulsion of the trimethylaluminum
sulfinate (with the assistance of the sulfur lone pair) to create thionium ion (2.50).
Further abstraction of the -proton by the base leads to desired dienylsuflide
(2.51) in an E1-like fashion (Figure 2.9).8,14
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CHAPTER 3: DEVELOPMENT AND APPLICATION OF THE
VINYLSULFONE POLYPROPIONATE METHODOLOGY

3.1: Large Scale Generation of Dienylsulfone

Scheme 3.1: Large Scale Generation of Dienylsulfone

With the synthetic versatility of the vinylsulfone functional group being
apparent, an efficient strategy for polypropionate assembly was devised.
Efficacious methodologies employ large quantities of affordable and robust
starting materials. The 7-membered cross-conjugated dienylsulfone (3.5) is
obtained by a process requiring no purification. Cycloheptanone (3.1) and
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thiophenol are treated with the acidic clay Montmorillonite using a Dean-Stark
trap1,2 to afford the vinyl sulfide (3.2). Oxidation of vinylsulfide (3.2) by the in situ
generation of Br2 from Sodium Bromide, H2O23,4 and buffered Sodium Tungstate
provides access to 3.3 without the danger of manipulating 10 moles of liquid Br2.
The sulfide is oxidized to the sulfone using economic Noyori conditions5,6 H2O2,
methyltrioctylammonium hydrogen sulfate as a phase transfer catalyst (PTC),
Na2WO4 & H2PO3Ph buffer (this would be the first example of using a 1%
catalytic buffer—Phosphinic acid provides a ligand on the tungstate that gives
better solubility and therefore reactivity). Treatment of the resulting bromo
sulfone with stoichiometric pyridine provides the pyridinium bromide salt (3.4)
precipitate which is isolated by vacuum filtration. The filter-cake is suspended
in diethyl ether and recollected via vacuum filtration to give a flocculent solid of
extremely high purity. 1,4 elim starting with the gamma allylic hydrogen. of the
pyridinium salt using 1,4-diazabicyclo[2.2.2]octane (DABCO), in aqueous
conditions yields the desired 7-membered cross-conjugated dienylsulfone (3.5)
precipitate (>98% pure) collected via vacuum filtration and air dried to furnish
65% yield over 5 steps.4 With the starting material obtainable in Kg amounts with
relative ease of operation, a polypropionate strategy based on the 7-membered
dienylsulfone is well positioned to exert a high degree of synthetic utility.
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3.2: VinylsulfonePolypropionate Algorithm

Scheme 3.2: Vinylsulfone Polypropionate Algorithm

When developing a polypropionate synthetic strategy, it is essential to
have an iterative process for generating the contiguous chiral centers. Much of
the fundamental chemistry had been established on the 5 and 6 membered
vinylsulfone scaffolds.7-9 Exploiting the prochiral nature of the dienylsulfone (3.5),
the Jacobsen Salen catalyst affords the chiral epoxide (3.6) in high enantiomeric
excess.10,11 Epoxyvinylsulfone (3.6) is directly methylated via nucleophilic attack
or indirectly by Lawton SN2’

12,13

substitution to give the dipropionate (3.7). Base

generates the dianion. Quenching of the dianion with diphenyl disulfide gives the
sulfenylated allylsulfone (3.8) which bears extremely favorable electronics for
1,4-elimination via activation of the sulfone with Lewis acid to afford the
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dienylsulfide diad (3.9).11 The acid labile dienylsulfide diad is immediately
oxidized to dienylsulfone diad (3.10). Asymmetric Jacobsen epoxidation begins
the second application of the algorithm. Direct or indirect cleavage of the chiral
epoxide (3.11) with methyl anion will depend on whether syn or anti configuration
is desired. The final epoxide substitution yields the vinylsulfone stereotetrad
(3.12), comprising the vinylsulfone polypropionate strategy.

3.3: Application of Vinylsulfone Polypropionate Methodology.
The C5-C11 syn, anti, syn Blue Fragment (3.13)
The first introduction of asymmetry on the target was achieved using
methodology developed by Du Jardin, by the
Jacobsen epoxidation using Salen catalyst with
hydrogen peroxide, ammonium tetrafluoroborate,
and sodium phosphate.14-21
Hong utilized Lawton SN2’ addition to the
Figure 3.1: C5-C11

epoxyvinylsulfone (3.14) by 3,5-dimethylpyrazole
(3,5-DMP) to afford the allyl alcohol (3.15).12,13,22

The pyrazole and hydroxy moieties direct the methyl Grignard in a second
irreversible SN2’ addition to the vinylsulfone to form the vinylsulfone
monopropionate (3.16) with a syn landscape. From this point Noshi-optimized
methodology, allowed multigram quantities of the stereotetrad to be obtained with
relative ease. Sodium hexamethyldisilazide (3.3 eq.) forms the dianion which is
quenched with diphenyldisulfide to give an allylsulfone protected with TES-Cl &
imidazole in methylene chloride to furnish (3.17).23 3.17 is eliminated with
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trimethylaluminum and Hünig’s base to provide the dienylsulfide11 which is
oxidized under Noyori conditions to the dienylsulfone diad (3.18).24 The
dienylsulfone is then epoxidzed using the achiral reagent dimethyldioxirane
(DMDO)25,26 to provide the asymmetric epoxide (3.19) 20 : 1 de in a trans
relationship to the methyl group. SN2’ addition by 3,5-dimethylpyrazole to the
epoxy vinylsulfone forms 3,5-DMP adduct (3.20).11,13 Pyrazole-alcohol directed
methyl

Grignard

addition

to

the

vinylsulfone

and

subsequent

3,5-

dimethylpyrazole (3,5-DMP) displacement provides the 7-membered vinylsulfone
dipropionate. t-Butyl dimethylsilyl (TBDMS) ether formation using TBDMS triflate
gives the disilyl ether. (+)-Camphor sulfonic acid selectively cleaved the less
hindered, more labile triethylsilyl ether (TES) to give 3.21.27-31 With the cyclic
vinylsulfone stereotetrad (3.21) now in hand, oxidative cleavage of the
vinylsulfone olefin was examined to determine the most efficacious way to obtain
the termini-differentiated dipropionate fragment.
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Scheme 3.3: Vinylsulfone Polypropionate Strategy C5-C11 (Noshi, Hong)
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3.4: Application of Vinylsulfone Polypropionate Methodology C21-C27 Red, C28C34 Green Fragments syn, anti, syn
Since a syn, syn, anti relationship was required for
aplyronine A fragments C21-C27 and C28-C34, a
methodology providing the anti-monopropionate
relationship via epoxide modification was required.
Epoxidation

of

the

starting

cross-conjugated

dienylsulfone (3.5) was effected under established DuJardin

Jacobsen

conditions.14,32-34 All subsequent operations optimized by Noshi were used. The
epoxide (2.15) was cleaved using the trimethylaluminum-aluminoxane complex
to provide the anti-monopropionate (3.22).11,24 The dianion formed with sodium
hexamethyldisilazide was quenched with diphenyldisulfide to give the allylsulfonyl
vinylsulfide (3.23).11,35-39 The free hydroxyl was silylated with TES-Cl to provide
the silylether (3.24). 1,4-Elimination11,36 via trimethylaluminum and Hünig’s base
yielded the cross-conjugated dienylsulfide (3.25) that is immediately oxidized to
sulfone (3.26) with hydrogen peroxide, PTC & sodium tungstate.5,6,40 The
dienylsulfone diad was epoxidized using the (S,S)-Mn-Salen catalyst, 4-(3phenylpropyl)pyridine N-oxide (P3NO) and sodium hypochlorite to give the cisepoxide (3.27).41,42 SN2’ addition to the vinylsulfone functionalizes the epoxide in
a 1,4-fashion to give the DMP adduct.11 Directed Grignard13 methylation delivers
the syn, syn, anti landscape. TBDMS triflate forms the more robust silylether at
C23 to give the diprotected stereotetrad
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Scheme 3.4: Vinylsulfone Polyproprionate Strategy C21-C27
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that was selectively deprotected by using (+)-CSA28-31,43 to cleave the triethylsilyl
ether at what will become C25. The original plan for the green fragment (C28C34) utilized the enantiomer of the red fragment (C21-C27), therefore employing
identical chemistry. The standard polypropionate algorithm intended for
producing the green fragment, while sufficient in yielding the desired chiral motif,
was incapable of giving the desired spacing on the carbon backbone. An
alternate variant of the vinylsulfone polypropionate methodology was explored to
obviate this issue. Finding a solution to the difficulties presented by the green
fragment, C28-C34 is central this thesis as will be made clear in the ensuing
chapter.
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CHAPTER 4: IN DEPTH EXAMINATION OF THE APLYRONINE
ACTIN BINDING TAIL REGION

4.1: Introduction

Figure 4.1: The Actin Binding Tail Region C23-C34

As can be seen in Figure 4.1, the structure of the actin binding tail (C24C34) is conserved in aplyronines A-C. An effective route to deliver the C24-C34
architecture would make these rare polyketide molecules more available for
further study. The current synthetic strategy for assemblage of the C21-C27
stereotetrad has been previously reviewed (Chapter 3, Scheme 3.4). The
“vinylsulfone polypropionate strategy” has proven its effectiveness with fragments
C5-C11 and C21-C27.1-3 The actin binding tail C28-C34 of aplyronine A proved
very resistant to the vinylsulfone polypropionate methodology. As will be seen, a
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key to this methodology is having the vinylsulfone properly substituted preoxidative cleavage (O3, OsO4) as shown in Figure 2.7. To better gain an
understanding of the synthetic challenges the actin binding tail presents, efforts
by other synthetic groups will be surveyed.
Calter and Guo used a strategy based on derivatives of asymmetric
ketene dimers constructed from cinchona alkaloid catalysis4 to assemble the
C28-C34 aplyronine A fragment.

Figure 4.2: Synthesis of the C28-C34 Fragment (Calter)

Calter and Guo began with the aldol adduct 4.2 prepared by the reaction of the
enolate

derived

from

ketene

dimer

4.1

with

α-(p-methoxybenzyloxy)

acetaldehyde (Figure 4.2) as an inseparable mixture of diastereomers in a 6:1
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ratio. After silylation of the mixture, the diastereomers were still inseparable.
Treatment of this mixture of diastereomers with lithium triethylborohydride
(LiBEt3H) reduced the major diastereomer without affecting the minor compound,
allowing isolation of 4.3 as a diastereomerically pure compound. Protection of the
C31-hydroxyl as a benzyloxymethyl (BOM) ether afforded 4.4. Homologation was
required to fully elaborate the C28-C34 fragment. Reduction of 4.4 to the
aldehyde, followed by Wittig reaction yielded monosubstituted olefin 4.5.
Hydroboration gave primary alcohol 4.6 which was silylated followed by removal
of the PMB group. Dess–Martin oxidation yielded aldehyde 4.7. It is worthy of
note that a homologation was required to realize the C28-C34 fragment.

The Marshall Stereotriad Strategy

Marshall and co-workers developed a strategy focusing on the central
stereotriads and using the chiral alcohol moieties as points of coupling (Figure
4.3). Using a very well developed methodology5-10 involving enantioselective
additions of chiral allenylindium reagents to chiral aldehydes, the Marshall group
was able to effect a number of complex natural product syntheses.10
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Figure 4.3: Allenyl Indium Generation of Stereotriads

Figure 4.3 highlights the allenylindium (4.10, 4.11) formation from the
chiral propargyl mesylates (4.8, 4.9). Though indium is shown here, a number of
different metals have been successfully utilized.10 Chiral aldehyde 4.12 was
obtained using the Roush variant of the Brown crotylboration.11The synthesis of
the C29-C34 fragment (Scheme 4.4) begins with attack by lithium acetylide on
acetaldehyde to deliver propargyl alcohol (4.16). MnO2 oxidation of the alcohol
gives 4-TIPS-3-butyn-2-one (4.17). The reduction of 4-TIPS-3-butyn-2-one (4.17)
with ca. 1 mol % of the Noyori chiral Ru catalyst (4.18) in isopropyl alcohol
proceeds rapidly to afford (S)-TIPS-3-butyn-2-ol (4.19) in >95% yield and >95%
enantiomeric purity. The corresponding mesylate (4.21) is converted in situ to
chiral allenylindium reagent, which reacts with aldehyde (4.22)11 to form
homopropargylic alcohol (4.23) with high diastereo- and enantioselectivity.
Hydroboration-oxidation of the derived alkyne 4.24 led to a separable 85:15
mixture of aldehyde 4.25 and alcohol 4.26.
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Figure 4.4: Synthesis Of The C29- C34 Fragment (Marshall)

Aldehyde 4.25 was reduced with DIBAL-H, and the combined alcohol
product 4.26 was protected as PMB ether 4.27. The use of dicyclohexylborane in
DME for

this

hydroboration

gave

a

significantly higher yield of the

aldehyde/alcohol mixture than BH3•THF or catecholborane. The formation of the
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alcohol byproduct 4.26 may result from in situ reduction of the intermediate
aldehyde by borohydride species, R2B+(H)OH-, produced during the basic
oxidation procedure. However, in the case at hand, this side reaction is of no
consequence. TBS ether cleavage of 4.27 and oxidation of the alcohol 4.28 gave
the aldehyde 4.29 representing C29-C34 of the targeted subunit.
Kigoshi, Suenaga and co-workers assembled the C28-C34 stereotetrad by
utilizing an asymmetric aldol strategy. The synthesis of C29–C35 segment 4.36 is
shown in Figure 4.5.

Figure 4.5: C28-C34 via Asymmetric Aldol Coupling (Kigoshi).
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Compound 4.36, with four contiguous syn, anti, anti-stereocenters, was
previously prepared by using the Evans aldol reaction and Sharpless epoxidation
as the key steps,12,13 the improved synthesis of 4.36 used the Paterson aldol
reaction14,15 as the key step. Thus, the Paterson aldol reaction between ethyl
ketone 4.31 and crotonaldehyde 4.30 gave the hydroxy ketone 4.32.
Stereoselective

reduction

of

4.32

with

tetramethylammonium

triacetoxyborohydride afforded an anti-1,3-diol, which was transformed into
acetonide 4.33. Conversion of 4.33 into the aldehyde 4.34 was effected by a
four-step sequence of reactions. Aldehyde 4.34 was treated with pyridinium ptoluenesulfonate (PPTS) in methanol to provide a separable mixture of
diastereomeric acetals, 4.35a and 4.35b, and the dimethyl acetal 4.35c. The
stereochemistry at C34 of acetals 4.35a and 4.35b was not determined. After
chromatographic separation, two minor products, 4.35b and 4.35c, were
subjected to equilibration (PPTS in methanol) to afford a mixture of 4.35a, 4.35b,
and 4.35c, from which the major acetal 4.35a was again obtained. By repeating
this procedure, 4.35b and 4.35c could be transformed into 4.35a. Protection of
the hydroxy group in 4.35a followed by oxidative cleavage of the double bond
provided the C29–C35 segment 4.36 (48% from 4.31).
As can be seen, while the above examples are elegant, they each suffer
drawbacks. The Calter ketene dimer methodology gives low yields and mixtures
of diastereomers that must be carried multiple steps before they can be
separated. These drawbacks waste reagents making large-scale endeavors
costly. The Marshall allenylinduim strategy has great potential. The main
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drawback being that the triisopropylsilyl acetylene is needed for greatest facial
selectivity and the price makes large-scale projects less attractive. The Kigoshi
aldol strategy is excellent in that it produces the full stereotetrad. It doesn’t suffer
from the need for a stoichiometric amount of chiral auxiliary like the traditional
Evans methodology. The main drawback is equilibration of the lactols and
dimethyl ketal. On a large scale (> 250 g) a re-equilibration can prove onerous. It
was the hope of the Fuchs lab that many of the limitations inherent in other
methodologies could be remedied with the vinylsulfone polypropionate
methodology.
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4.2: C28-C34 Green Fragment Backbone Strategy 1st Generation

Scheme 4.1: Original Fuchs group approach to C28-C34

The first attempt by El-Awa to solve the structural deficiencies of tetrad
4.46 involved a desperate oxidative cleavage of a carbon at one terminus and
subsequent installation of the methylformamide via the Wittig olefination at the
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opposite end. Ozonolysis of 4.46 with NaHCO3, methylene chloride and reductive
work-up with Me2S, and t-BuNH2 gave the stereotetrad lactone core ethyl alcohol
(4.49). Selenylation of the terminal alcohol with ArSeCN, Bu3P and H2O2,
followed by oxidative elimination affords terminal olefin (4.50), which is then
amputated by ozonolysis and reductive work-up (Me2S, t-BuNH2•BH3) to provide
the terminal alcohol 4.51, which is then protected as the TBDMS silyl ether
(4.52). The magnesium methoxymethyl amide cleaves the lactone to produce the
terminal Weinreb amide 4.53 while the free hydroxyl was protected as the BOM
ether 4.54. It was at this point that El-Awa stopped the sequence. The plan was
to effect reduction of the Weinreb amide to aldehyde 4.55 with DIBAL-H, with
subsequent olefination by the dimethyl formamide ylide 4.56, then I2 catalyzed
olefin isomerization16 to 4.57. Deprotecton of the C28 TBDMS-silylether (4.58)
followed by a Dess-Martin oxidation would supposedly give the properly
functionalized green fragment 4.59 in roughly 13 operations post oxidative
cleavage of the 7-membered vinylsulfone tetrad (4.46). The inelegance of this
synthetic strategy ultimately led to a cessation of inquiry into the cleavage
strategy (Scheme 4.1) for furnishing C28-C34 aplyronine A polypropionate
fragment.

78
4.3: C28-C34 Green Fragment Backbone Strategy 2nd Generation

Figure 4.6: A Proposed Improved Route to Green Segment 4.36

The above synthesis of the green segment deletes then later reintroduces
a carbon atom to the backbone (Section 4.2), a tactic that is conceptually
avoidable. The intention was to subject dihydroxy vinylsulfone 4.60 (or its mono
and diprotected variants) to the various reagents (phosphazene bases, Li, Na, K
amide anions) known to effect thermodynamic isomerization17 to the more stable
allyl sulfones 4.64-4.66 via intermediate allylic anions 4.61-4.63 (Fig. 4.6). The
Z1O group in the –position is equatorial, which should provide a measure of
protection from –elimination, even with the prized azidopivalate ester 4.63. As
can be appreciated, while the concept is easily stated, the number of
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experimental variants is potentially large. For example, treatment of 4.60 with
DBU in various solvents returns the starting material.17 It now appears that
polyanion experiments involving 4.61 and 4.62 followed by kinetic quench in the
α–position will be required. Once having obtained 4.66, ozonolysis to hydroxy
dialdehyde 4.67 can be undertaken. In such a case direct double bond
differentiation would likely be sacrificed as the sulfinic acid leaving group would
no longer be part in the oxidative cleavage. This pseudo-symmetrical
intermediate can provide lactol products from alcohol attack at either aldehyde.
While the α–sulfonylaldehyde should be more reactive18 and 5-ring –
pivaloxyaldehydes

may

suffer

ring

opening,19

to

allow

thermodynamic

equilibration of the two lactols to a mixture rich in 4.68. Desulfonylation prior to
ozonolysis and adjusting the timing of azidopivalate addition are additional
options. In the final analysis, the brevity of this approach to C28-C34 underwent
careful evaluation. Ultimate introduction of the N-formyl enamine moiety was to
directly follow the Yamada precedent using the 5-ring methoxyacetal, which has
since been improved by other syntheses18,20-23 introducing this important
recognition element from a terminal aldehyde. Since the goal is to provide
aplyronine A analogs and biotools, the plan will exploit the successes by Yamada
and Paterson in their syntheses.12,24
Subsequent experimentation illustrated the inefficacy of such an
approach. Isomerization and equilibration of the vinylsulfone to the allylsulfone
cannot be executed, possibly due to the steric encumbrances imposed by the
four stereocenters on the tetrad.25 It is necessary for the orbitals on the α, β and
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γ–sulfone carbons to align in the same plane to deliver the allylsulfone from the
vinylsulfone. The impasse for the vinyl to allyl sulfone equilibration effectively
eliminates this strategy as a viable option.
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4.4: Surrogate Methodologies En Route to the C28-C34 Fragment

Figure 4.7: Isomerization via Allylic Oxidation

Due to the apparent inability of the stereotetrad to form the allylanion, an
allyl radical pathway was investigated (Figure 4.7). The initial strategy attempted
entails an oxidation at the –position on 4.46. Many conditions to effect an allylic
oxidation were examined.25 Treating 4.46 CCl4, azobisisobutyronitrile (AIBN), and
N-Bromosuccinimide (NBS) gives yields of bromide (4.69) ranging from 50% to
65%, while alternate conditions26 enabled no improvement.
The free radical bromination yielded multiple spots on chromatography
plates. The reaction generates a stoichiometric amount of HBr, which is
problematic for silyl ethers. This fact coupled with the apparent ketone (iii)
formation due to hydrogen abstraction during the course of the reaction made for
an inefficient conversion (Figure 4.8). Due to lack of viable alternatives, the allyl
bromide (4.69) was further utilized.
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Figure 4.8: Radical Bromination Ketone Formation

Bromide 4.69 was treated with sodium phenylmercaptide (3-10 eq.) to
provide 4.70. With vinylsulfide 4.70 in hand the electronic configuration favorable
to elimination of the sulfone was established. Unfortunately the previously used
1,4-elimination was ineffecive (Figure 2.9). Due to limited supply of 4.46 model
studies were undertaken; 4.38 was deemed an acceptable proxy for 4.46.
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Figure 4.9: Desulfonylation Ventures

Reductive cleavage of the allylsulfone with Raney nickel27 at reflux in
ethanol returned starting material. Sodium-Mercury amalgam with phosphate
buffer was successful but deemed substandard for anticipated large-scale
operations. Attempted reductive cleavage of the allylsulfone by tributyltin hydride
and AIBN28 also returned of starting material. A continuation of the reductive
cleavage concept making use of lithuim metal and naphthalene29 likewise
returned starting material. A more effective electron transfer reagent samarium
iodide, DMPU, methanol, and THF30 again yielded starting material. Indium31
likewise led to fruitless results. Such observations brought into doubt the efficacy
of the established polypropionate strategy for use in the assembly of the C28C34 green fragment. Success with White conditions
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Figure 4.10: White Conditions

Pd(OAc)2, DMSO, and 1,3-Bis(diphenylphosphino)propane32 met on the
dipropionate model but coupled with the fact that green tetrad was limited and
the bottleneck caused by considerable degradation in yield of the nbromosuccinimide (NBS) oxidation this methodology was abandoned.
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4.5:The Stork-Sophia Strategy

Figure 4.11: Stork Sophia Route to Green Tetrad

Dimethylamine is well established in the Fuchs group as an excellent SN2’
Lawton nucleophile for epoxyvinylsulfone 4.42.1 Hoffmann conditions33 on 4.42
would

furnish

dienylsulfone

4.73

with

the

,–olefin

at

C28-C34.

Bromomethyldimethylchlorosilane, and excess triethylamine delivers silylether
4.74. Radical initiation with azobisisobutylonitrile (AIBN), heat or light with tri-nbutyltin hydride provides siloxane

34-40

4.76 which would be hydrolyzed to 4.7741
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(Figure 4.11).This synthetic scheme would allow exploration of the chemistry
proposed in Figure 4.7.

Entry

Conditions (c)

Result

1

t-BuLi, THF, -78 °C
tris(pyridin-2-ylmethyl)amine
AIBN, Bu3SnH, Bz, 80 °C
tris(pyridin-2-ylmethyl)amine,
AIBN, Cu(II)Br, tol. 110°C
In, THF:H2O (5:2)
25 °C, 24 hrs.
1-Naphthylamine,
N,N-dimethyl-,
Li, THF, -55 → -40 °C

Deprotecton

2
3
4
5

Bromine Reduction
Bromine Reduction
Recovery of
Starting Material
Recovery of
Starting Material

Figure 4.12: Stork Sophia on Vinylsulfone

Due to the scarcity and value of epoxide 4.42 and lack of precedent of this
methodology on –hydroxy vinylsulfones, 4.79 was utilized as the model
substrate. Unfortunately silylether 4.79 proved extremely acid labile and storage
in a Teflon vessel was necessary. Metallation of the bromomethyl moiety with t-
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butyllithium led to deprotection (Entry 1). Unfortunately attempts at forming the
radical with AIBN under any conditions (Entries 2 and 3) simply afforded the
direct reduction product, the TMS ether. Reduction by single electron transfer
using Indium, or Lithium metals (Entries 4 and 5) led to recovery of starting
material, and deprotecton of the silylether respectively.
The Stork-Sophia free radical cyclization is a methodology that has been
long anticipated as becoming a facet of the vinylsulfone polypropionate
methodology and it was therefore necessary to review the group literature to see
if any insights could be gleaned from past exploration.
A reexamination of the work of Inchul Kim42 proved to have exceptional
value. In an effort to expand the scope of the vinylsulfone polypropionate
strategy, Kim investigated intra/ inter-molecular, SN2’ Lawton anionic cyclization
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Figure 4.13: Syn Methylation Lawton Strategy (Kim)

4.85
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The construction of syn-relationship was tried previously with 6-epoxy-3hydroxy-vinylsulfone 4.81 by using the hydroxyl group as a silicon tether. A trial
with methyllithium expecting a directing effect of lithium alkoxy group did not
afford any syn-addition product 4.82. Treatment of 4.83 with tert-butyllithium did
not give siloxane 4.84 but only give the protonated compound 4.85 (Figure 4.13).

Figure 4.14: Kim Probe of Stork-Sophia Photocyclization

The diad 4.86 was converted to bromomethyldimethylsilyl ether 4.87.
Intramolecular alkylation of this material was effected by low temperature
treatment of LiHMDS, which provided annulated siloxane 4.88. While the
literature has several examples of anionic cyclizations that occur via initial intramolecular attack at the silyl moiety followed by rearrangement,43 this is
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apparently the first example of anionic formation of a siloxane from the familiar
Stork halomethylsilyl ether functionality.36 The success of this reaction with the
avoidance of 1,3-elimination presumably is partially due to the delocalized soft
nature of the sulfone stabilized pentadienyl anion. For the siloxane cleavage,
protiodesilylation was attempted using the Hoveyda method.44 However, even
though TBAF in DMF seemed to effect partial cleavage of the siloxane, the
fluoride anion was basic enough to deprotonate the allylic proton of the
desilylated 4.88 resulting in small amounts of vinyl sulfone 4.90 together with
unknown side products. Aqueous workup afforded the siloxane-opened silanol
4.91, which was also subjected to the above condition. However, it only yielded a
fluorinated mixture. The Kumada-Fleming-Tamao oxidation was also applied to
siloxane 4.88 anticipating conversion to hydroxymethyl compound 4.89. Under
these conditions, the olefin in the starting material was reactive enough to result
in multiple side products (Figure 4.14).
From the data provided by this work some key insights could be
extrapolated. Operating on the homoallylic alcohol rather than the allyl alcohol is
far more effective. Finding a way to alter current methodology to allow
exploitation of the homoallyl rather than allyl alcohol had to be deduced. Pursuit
of a design alteration allowing for utilization of the homoallylic alcohol paved the
way for a profound increased understanding of the capability and versatility of the
vinylsulfone polyproprionate methodology.
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4.6: C28-C34 Green Fragment via a “Pivot Strategy”

Figure 4.15: Vinylsulfone Transposition Strategy

Pursuant to obtaining the C28-C34 stereotetrad with the transposed
vinylsulfone (4.70) a new perspective was sought. Rotating Fragment (4.60) on
the y-axis through the x,z-plane gives the perspective of inverted chiral centers
(4.69-rot). Transposition of the vinylsulfone from C33-C34 to C34-C28 furnishes
4.70, a target that meets strategic structural needs (Figure 4.15).
Based on the Kim success with the allylanion of 4.87 a stepwise
retrosynthetic analysis was designed that utilized the siloxane annulation. SN2’
on epoxide 4.72 with sodium borohydride should yield tetrad 4.71. Epoxidation
with dimethyldioxirane (DMDO) from stereotriad 4.73 should furnish the
penultimate epoxide 4.72. Treatment of 4.74 with Bu4N+•F–, SiO2, in DMF
provides 4.73.41

Intramolecular annulation of sulfone 4.75 allylanion with

LiHMDS should provide the fused siloxane ring 4.74. Bromomethylsilylether 4.75
is obtained from dienyl alcohol 4.76.36 Noyori conditions on sulfide 4.77 delivers
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sulfone 4.76. Activation of sulfone 4.78 followed by 1,4-elimination using
trimethylaluminum and Hünig’s base affords the acid sensitive dienylsulfide 4.77.

Scheme 4.2: Retrosynthesis of the Vinylsulfone Transposition Target
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Dianion formation with phenyldisulfide quench of 3.16 affords 4.78.
Retrosynthetic steps i-k are identical to methodology in Scheme 3.3 steps 1-4. All
of the chemistry in this analysis has been well established-save that of the
siloxane ring formation and subsequent oxidation, so steps c and d in Scheme
4.2 provide the most compelling points of investigation.
Fortunately previous to his departure, Wan Pyo Hong, provided a
significant amount (~40 g) of Blue allylsulfone intermediate 4.78 triethylsilyl ether.

Entry
1
2

3

Conditions
Result
Decomposed on
LDA, THF, 0.1 M, 78 °C⟶
Silica
20 °C, 30 m
n-BuLi, THF, 0.1 M,
TMS Ether
78 °C⟶ 20 °C, 30 m
Recovery

LDA, THF, 0.1 M, HMPA,
78 °C⟶ 20 °C, 30 m

Figure 4.16: Anionic 5-exo-tet Siloxane Cyclization

Unfortunately other than concept, Kim left little in the way of spectra (one
very crude NMR) or detailed methodology with which to work with. This did
however present the opportunity to re-explore the cyclization methodology
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virtually from scratch. A brief cross-section of reaction attempts is shown in the
above table. Traditional LDA conditions provided a repeatedly non-isolable spot
on TLC (Entry 1). N-Butyllithuim in THF allowed for recovery of TMS ether (Entry
2) but HMPA, in standard LDA conditions gave the triene 4.79 in quantitative
yield.

Scheme 4.3: Triene 4.79 Formation Mechanism

Formation of triene 4.79 starts with proton abstraction of 4.75 to furnish
the allylanion. Nucleophilic attack of the allylanion on the bromomethyl silyl ether
moiety delivers siloxane 4.80. Additional base induces -elimination causing an
opening of the siloxane ring to afford triene 4.81. Tetrabutyl ammonium fluoride
(TBAF) gives 4.79 in quantitative yields.
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Scheme 4.4: C32 des-Methyl Aplyronine A Analogue Target

Time constraints dictated that the siloxane formation step be delayed until
a later time. This development facilitated C32 des-methyl of aplyronine A
analog 1.7 as the new target. Fragment 4.80 would be the working target for this
new synthetic investigation. Stereotriad 4.81 is the ultimate cyclic vinylsulfone
target for the C28-C34 fragment (Scheme 4.4).

95

O
S O
10

O
8

9
7

S

11

5

6

O
Si

a

O
Si

S

3.17

c

4.86
3.18

b

N3
HO

d

S
O O 4.82

N3
O

O
Si

e

O
Si

S
O O 3.19

O

S
O O 4.84

O
O
Si

f

O
OH

S
O O 4.85

O
N3

OH
4.83

(a) DIEA, AlMe3 (b) PhPO(OH)2, oct3MeNHSO4, Na2WO4, tol.95% 2 steps (c) (R,R)-Mn salen,
NH4OAc, urea H2O2 88% (d) NaBH4, MeOH 82% (e) 4.83, (COCl)2, DMF, DMAP,TEA 75% (f)
(1S)-(+)-10-Camphorsulfonic acid, MeOH or CeCl3, MeOH 78%

Scheme 4.5: Green Triad Transposed Vinylsulfone

Fortunately the new scheme was implemented with little difficulty.
Allylsulfone 3.17 smoothly converts to dienylsulfide 4.86 upon treatment with
trimethylaluminium and Hunig’s base. Noyori Oxidation of 3.17-sulfide delivers
sulfone 3.18. Jacobsen Epoxidation of diene 3.18 with the anhydrous H2O2
source urea hydrogen peroxide, provides epoxide 3.19. Sodium borohydride
reduction of 3.19 provides alcohol 4.82 in acceptable yield. Azido acid 4.83 forms
the in situ acid chloride with oxalyl chloride, dimethylformamide (DMF),
dimethylaminopyridine (DMAP), and triethylamine (TEA). Esterification of 4.82 to
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azido ester 4.84 occurs smoothly. Cleavage of the silylether on 4.84 with
camphorsulfonic acid or cerium chloride yields target 4.85. With the Green Triad
in hand oxidative cleavage of the vinylsulfone was next explored.
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CHAPTER 5: OXIDATIVE CLEAVAGE OF CYCLIC VINYLSULFONES

5.1: Oxidative Cleavage of Cyclic Vinylsulfone Stereotetrads
Oxidative cleavage of cyclic vinylsulfone stereotetrads via ozonolysis has
been investigated extensively by Noshi.1,2 Subsequent exploration of the
ozonolysis methodology by Hong3,4 has established sound methodology for the
C5-C11 & C21-C27 linear fragments. An encapsulation of the methodology
achived by Noshi & Hong starts with an examination of the C5-C11 fragment.

Scheme 5.1: Synthesis of the C5-C11 Segment (Noshi, Hong)

Ozonolysis of 3.21 provided lactone 5.2 via intermediate 5.1 in good yield
(70%). Protection of the alcohol 5.2 as TBS ether 5.3, followed by lithium
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borohydride (LiBH4) induced lactone cleavage, afforded the linear fragment 5.4.
5.4 was converted to triol 5.5 and then protected as p-methoxybenzylidene acetal
5.6 as a single diastereomer. Tosylation of primary alcohol 5.6 followed by
iodination furnished fragment 5.7 (Scheme 5.1).
It is advantageous to open lactones with methoxymethylamine anion to
give Weinreb amides5-7 as termini-differentiated linear fragments. Exploration by
Noshi elucidates the lactone opening by metallated amides on the C5-C11
fragment.



Opening of lactone 5.3 via Weinreb amineǜHCl/ i-PrMgCl is not successful
even when 10 equivalents of nucleophile were added at 25 ϶C instead of -10 ϶C.
In all attempts, starting 5.3 was recovered quantitatively without any linear
fragment 5.8 in evidence. Lactone 5.3 however was smoothly opened employing
dimethylamineHCl/i-PrMgCl on scales 3-4 g to afford dimethyl amide 5.91
(Scheme 5.2). Ultimately, as can be seen in Scheme 5.1, LiBH4 was ultimately
chosen for opening of lactone 5.3 to diol 5.4.
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As will be seen, control of the termini differentiation of the C21-C27
fragment is absolutely critical to the attainment of the aplyronine A analog.
Inquiry by Noshi and elucidation by Hong established a solid foundation for the
acquisition of the linear C21-C27 fragment.

The synthesis of C21-C27 intermediate 5.19 commences with ozonolysis
of 3.29 followed by reduction to afford lactone-alcohol 5.12 via intermediate 5.11.
DCAD (5.13) Mitsunobu coupling of 5.12 delivers 5.14 followed by lactone
opening

generated

Weinreb

amide5

5.15.

Treatment

of

5.15

with

t-
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butyldimethylsilyl triflate (TBSOTf) gives disilylether 5.16, which was transformed
to terminal alcohol 5.17 via the intermediate aldehyde. TIPS protection was
successful using TIPSOTf/2,6-lutidine at -78°C giving 5.18 in 88% yield.
Oxidation with m-chloroperoxybenzoic acid (MCPBA) provided the C21-C27
linear Julia-Kocienski8,9 sulfone intermediate 5.19.
The studies of Noshi & Hong on linear fragments C5-C11 & C21-C27
gives clear vision as to how the C32 des-methyl cyclic stereotriad 4.85 can be
utilized.
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5.2: Oxidative Cleavage of the Vinyl Sulfone – Ozonolysis

(a) O3, NaHCO3, -78 °C, DCM: MeOH (5:1); (b) Me2S
Figure 5.1: Ozonolysis of Green Vinylsulfone Stereotriad

Ozonolysis of C28-C34 stereotriad 4.85 has considerations beyond those
of stereotetrads 3.21 & 3.29. Ozonolysis of 4.85 in methylene chloride / methanol
(4:1) likely passes through molozonide 5.20. Decomposition of 5.20 presumably
exclusively yields Criegee zwitterion 5.21 due to the instability of 5.22. Secondary
ozonide formation is arrested by an intramolecular attack (5.21). The free alcohol
of 5.21 is five atoms away from both electron-deficient terminii. C31 alcohol could
either add to the acylsulfone delivering 5.24 (Pathway B) or add to the carbonyl
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oxide to give lactol 5.23 (Pathway A) shown in Figure 5.1. Unlike the C5-C11
fragment (3.21) and C21-C27 fragment (3.29), which have a free hydroxyl
positioned 4 atoms from the carbonyl oxide and 6 atoms from the acylsulfone.
This arrangement leads stereotetrads 3.21 & 3.29 exclusively forming 6membered lactones upon ozonolysis.

The reactivity of the carbonyl oxide

however is greater than that of the acylsulfone, and 5-membered lactol 5.23 was
furnished as a ~3:1 NMR ratio of the two possible diastereomers. The 5membered lactol was however very resistant to coupling efforts.

Figure 5.2: In Situ Aldehyde Generation From Lactol

Expectations of lactol 5.23 were initially very optimistic. Deprotonation of
lactol 5.23 would, under ideal circumstances lead to an equilibrium with –alkoxy
aldehyde 5.25. An irreversible olefination (Wittig or Julia-Kocienski) would trap
the aldehyde driving equilibrium to completion. For example, Boger condensed a
similar lactol with the Still-Gennari phosphonate ((CF3CH2O)2P(O)CH2CO2Me,
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KHMDS, 18-crown-6, THF, -78 °C) to afford the first cis olefin of a sensitive
Z,Z,E-triene (88%, Z:E 29:1) in his total synthesis of fostriecin (CI-920).10
Fernandez de la Pradilla examined the Wittig reaction on a similar unprotected
lactol that cleanly led to an unsaturated ester (67:33, E/Z mixture) and the
smooth base-catalyzed cyclization of led to a 75:25 mixture of epimers that are
key intermediates in the formal synthesis of kumausyne and kumausallene.11
After olefination, the δ alkoxide would be either quenched on work up delivering
linear ester or form a cyclic 5-membered lactone Figure 5.2.

Conditions: LiHMDS (1.2 eq), THF: HMPA (5:1), ̶ 78 0 °C, 30 min 22%
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N N
N
N
S
O O Ph

N/R

5.29

N/R

5.29

N/R
N/R

107
Entry
5
6

Conditions
DBU, THF
-40 °C→25 °C
30 min
NaHMDS, THF
0 °C→25 °C, 45 min

Nucleophile

Result

5.30

N/R
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Scheme 5.4, contd.

Lithium hexamethyldisilazide with HMPA and THF at -78- 0 °C, with 3 eq
of 5.27 effected olefination at the C21 end of the red fragment (5.28) in low but
promising yield (Scheme 5.4). Ultimately using either of the information-rich
polypropionate segments in excess would be an inefficient and untenable
strategy.

Pursuing

a

1:1

substrate

ratio

with

the

rare

C21-C23

p-

methoxybenzylidine 5.29 under the same conditions shows the lactol to possess
robustness beyond expectations, returning starting material. LiHMDS (1.2 eq),
THF:DMF:HMPA (3:9:1), -78→0 °C, 30 min, similarly returned starting material.
Using the stronger irreversible base NaH (50 eq), THF, -78→0 °C, 30 min,
returned a faint light blue spot upon para-anisaldehyde staining. NMR of the
crude material revealed no signals in the olefinic region possessing the requisite
AB splitting patterns. n-BuLi, THF, -42 →25 °C, 20 hr, with commercially
available 5.30, likewise furnished no desired product. In an attempt to see what
an amidine base could achieve, 5.30 was treated with DBU, THF, -40 °C→25 °C,
30 min but to no avail. As a last-ditch effort, NaHMDS, THF, 0 °C→25 °C, 45 min,
was attempted on substrate 5.30 but the weaker base did not affect the desired
transformation. It was readily apparent that the lactol functionality was not
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synthetically compliant. Revisiting past efforts in the Fuchs group revealed a
possibly more promising methodology for obtaining desired lactone 5.24.
Dihydroxylation of the vinylsulfone was next explored.
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5.3: Dihydroxylation Via Established Methodology

Reproducible dihydroxylation of vinylsulfones has been an elusive
methodology

for

oxidative

cleavage

of

cyclic

vinylsulfones.

Ideally

dihydroxylation via osmylation (Figure 5.3) would have osmium (VIII) oxide add
to vinylsulfone 5.24 to provide osmate 5.31. Hydrolysis of osmate 5.31 ejects the
sulfinic acid to deliver acyloin 5.32. Intramolecular addition by the free alcohol
gives -hydroxy lactol 5.33. Cleavage of diol 5.33 by lead (IV) acetate would
furnish lactone 5.24 via intermediate 5.34.
Previous work by Jiang12 focused primarily on the ability of Os(Vlll) and
Ru(Vlll) species to effect dihydroxylation of the electron deficient vinylsulfones.
While limited success with osmylation was indeed achieved using Bäckvall
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methodology,13 satisfactory results over a diverse cross section of multifunctional vinylsulfones was lacking.

Jiang employed the Bäckvall methodology for the conversion of vinyl
sulfone substrates to -hydroxyketones. Only one of several substrates (5.35)
gave a high yield of the desired -hydroxyketone (5.36 in RXN 1). The rest of the
cases examined gave either low yields or low conversion (Figure 5.4).
It was theorized that the low yield/conversion was due to steric hindrance
in vinylsulfones 5.35-epi, 5.37, 5.39 & 5.39-epi. This problem was addressed by
using Sharpless methodology by treatment with catalytic ruthenium dioxide and
sodium periodate.14
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Treatment of vinylsulfone 5.39-epi with 0.03 equivalents of ruthenium
dioxide and 2 equivalents of sodium periodate added in 3 portions was shown to
avoid or minimize the -hydroxyketone cleavage reaction. Treatment of 5.40-epi
with lead tetraacetate in methanol provided aldehyde-methyl ester 5.41-Me in
94% yield. Alternatively, use of 3 equiv. of sodium periodate in the ruthenium
dioxide reaction of oxabicyclic sulfone 5.39-epi directly gave aldehyde-carboxylic
acid 5.41 in 89% yield. Esterification of carboxylic acid 5.41 with methylisourea or
in situ diazomethane delivered aldehyde-methyl ester 5.41-Me (Scheme 5.5).
Oxidative cleavage of 5.36 with sodium periodate followed by esterification
of carboxylic acid 5.42 with methylisourea or in situ diazomethane gave
aldehyde-methyl ester 5.42-Me without difficulty. Application of the lead
tetraacetate/ methanol procedure again obviated the necessity to isolate
carboxylic acid 5.42 (Scheme 5.6).

112

Based on the work of Kim15 exploration of the osmium dihydroxylation
methodology was investigated. Stereotriad 4.85 was treated with NMO (N-Methyl
morpholine N-oxide), followed by an aqueous solution of osmium tetroxide (4
wt% in water) in a mixture of acetone and water and stirred at 0 °C25 ⁰C for 6
hours returned starting material (method a, Figure 5.5).
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The solvent was changed to THF:water (method b) likewise returning
starting material. Switching to osmium tetroxide 2.5 wt% in t-BuOH, 4-methyl
morpholine N-oxide in t-BuOH:THF:water (method c) showed no reaction after 18
hours. Changing to the Kim conditions (method d) of Scheme 5.4 showed no
reaction, which apparently eliminated osmylation as an option for oxidative
cleavage of stereotriad 4.85 (Figure 5.5).

Initially ruthenium catalyzed oxidative cleavage of the vinylsulfone using
sodium periodate was avoided, due to the need to esterify the terminal carboxylic
acid (Scheme 5.4). The ineffectiveness of osmium methodologies however
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necessitated investigation of the ruthenium approach. It is worthy of note that
none of the Kim substrates 5.35, 5.37, or 5.39 possessed any free alcohols.
Treatment of free alcohol 4.85 with catalytic RuCl3•H2O and stoichiometric NalO4
in CCI4:CH3CN:H2O (1:1:1.5), phosphate buffer pH 5, provided ketone 5.43 in
roughly 50% yield (Figure 5.6). Lack of literature precedent for the preservation
of the secondary alcohol under these conditions demanded examination of
silylether 4.84. Application of the aforementioned conditions but with a biphasic
solvent system returned starting material (a). Changing back to the single solvent
system (b) also yielded starting material. Kim conditions of RuO2, NalO4 in
CCI4:CH3CN:H2O (1:1:1.5), pH 5 (c) similarly returned starting material (Figure
5.6). At this point it seemed ozonolysis with both hydroxyl groups protected was
the only remaining option.
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5.4: Citric Acid Catalyzed Dihydroxylation

The proposed mechanism of osmium tetroxide (OsO4) dihydroxylation
(Figure 5.7) suggested that the rate is sacrificed if (mono)glycosylate ii is
hydrolyzed to regenerate diol and osmium tetroxide perpetuating the First
Cycle.16 The Second Cycle is favored over the First Cycle all things being equal.
Since the rate of hydrolysis (h1) is much slower than the reduction (r3), the
osmium(VI) bis(glycolate) iii builds up as the reaction progresses, generating diol
via hydrolysis of (bis)glycolate iii. To exploit the Second Cycle when using chiral
ligand, a slow addition technique was recommended to suppress the second
cycle pathway during asymmetric dihydroxylation (AD).16 However, if high
reactivity is required, the second cycle gives a clear advantage over the first
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cycle. Citric acid improves the rates and the yields of cis-dihydroxylations of
various electron-deficient alkenes. In addition to acting as a pH buffer thereby
preventing formation of insoluble Os(VIII) dioxoosmate iv, a species, that inhibits
the second cycle, citric acid strongly binds to OsO4 and maintains the reaction in
the second cycle.17
Addition of citric acid to improve the catalytic asymmetric osmylation
system led to a greater understanding of the catalytic cycle that the vinylsulfone
substrate undergoes. During the course of Sharpless’ investigation to improve
upon the Upjohn protocol, it was found that the osmylation catalytic cycle can, as
has already been stated, progress via two alternate avenues where the rate
limiting step is hydrolysis of the monoglycolate (i) in the case of the first cycle
and bisglycolate (ii) in the case of the faster second cycle Figure 5.7. When the
osmylation is undertaken in homogeneous conditions the co-oxidant (NMO) has
access to the intermediates over the entire catalytic cycle. Since the Second
Cycle is faster, the reaction gets locked into the second cycle (bis)glycolate (ii)
hydrolysis furnishes Os(VI) species iii. The Sharpless group postulated that
acids assist catalyst turnover by preventing formation of the catalytically dormant
dioxoosmate dianion species iv, which is formed upon deprotonation of the
hydrated (bis)glycolate iii at higher pH.
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Figure 5.8: Citric Acid Catalyzed cis-Dihydroxyltion of Vinylsulfones

The strong electron withdrawing ability of the sulfone contributes to the
acidity of the hydrated bis(glycolate) species iii•H2O thus increasing the
concentration of the dioxoosmate iv and crippling the cycle. The Sharpless group
then discovered, based on the aforementioned hypotheses that the dioxoosmate
iv is especially stable and resistant to substitutions of any kind under basic
conditions including hydrolysis irrespective of the presence co-oxidant. According
to Sharpless, all acidic mixtures remain green indicating the presence of neutral
bis(glycolate) (ii) whereas basic mixtures took on a reddish brown color
indicating the presence of dioxoosmate dianion species iv. Adding citric acid
however arrests the formation of osmium tetroxide (OsO4) in favor of species iii
thereby impeding the First Cycle (Figure 5.8). With proximal acidic moieties
acting as a buffer in hydrated (bis)glycolate iii•H2O and dioxoosmate iv the
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equilibrium leans strongly in favor of bis(glycolate) ii which can then be
hydrolyzed back to species i so the cycle may continue (Figure 5.8).
Methodology elucidated by Sharpless,18-20 involving dihydroxylation of
election deficient olefins by osmium, catalyzed by citric acid was explored on
green stereotriad 4.85. Rationale for the efficacy of the osmium/citric acid
methodology is derived from the proposed catalytic cycle in Figure 5.8.
It is noteworthy that olefins such as diethyl maleate show the greatest
benefit from performing the dihydroxylation at lower pH.18 The hydrated
osmium(VI) bis(glycolates) like species iii•H2O formed from such electron-poor
olefins would be expected to be much more acidic and correspondingly more
likely to get trapped as the unwanted dioxoosmate dianion iv, even in the
presence of a relatively weak base like 4-methylmorpholine. Citric acid however
not only coordinates to the osmium, but coordinates the acidic moieties proximal
to the oxygens of the hydrated (bis)glycolate iii so buildup of dioxoosmate iv will
not terminate the catalytic cycle.

Figure 5.9: Citric Acid Catalyzed Osmylation of Green Stereotriad C28-C34
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With a sound rationale for catalytic dihydroxylation of the electron deficient
vinylsulfone, further inquiry was made into the efficacy of this new osmylation
methodology on the vinylsulfone stereotriad. Under these conditions, the
osmylation smoothly provided -hydroxy lactol (83%; ~3:1 epimeric NMR ratio)
(Figure 5.9).
Lead tetraacetate instantaneously cleaves both -hydroxy lactol epimers
to the lactone-aldehyde (Figure 5.10).

Figure 5.10: Pb(OAc)4 Glycolytic Cleavage

With the proper C28-C34 chiral motif in hand, it is now possible to couple
the green fragment. Due to the ester at C29, the olefin coupling must entail the
aldehyde being attacked by the nucleophile rather than the nucleophile being on
C28 as the danger of beta elimination is too great.
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CHAPTER 6: C28-C34 STEREOTRIAD SYNTHETIC RAMIFICATIONS

6.1: Assembly of Aplyronine A Backbone
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With an iterative way to access polypropionate motifs from cyclic
vinylsulfones,1 a working, sequential and convergent strategy was devised to
assemble an aplyronine core.
Previous work done in the Fuchs group by El-Awa, Noshi and Hong
achieved synthesis of the C1-C27 segment of aplyronine A.2-4 Macrocyclic
lactone 6.1 (C1-C27 segment) was desired as a key fragment of the aplyronines.
As outlined in Figure 6.1, the synthetic approach is based on disconnection of
macrocyclic core 6.1. Core 6.1 is accessed from building blocks 6.6, 6.9 and 6.7.
Fragments 6.2, 6.4 and 6.5 are derived by vinylsulfone strategies creating
stereodefined polypropionate fragments. Side Chain 6.11 was originally to be
constructed as previously described in Schemes 4.2 & 4.3. Ozonolysis was the
designated methodology to access the desired acyclic segments. Fragment 6.2,
possessing the stereotetrad, (C7-C10 dipropionate portion) can be obtained from
cyclic vinylsulfone 3.21. Similarly, fragment 6.5 with a C23-C26 dipropionate
portion can be prepared from cyclic vinylsulfone 3.29. Fragment 6.4 was chosen
to introduce the C15-C20 array.3,5 As reported,6 β-ketophosphonate 6.3 was
adopted for connecting iodide 6.2 and aldehyde 6.7. Macrolactone 6.10 was to
have been joined to lactone 6.11 via a JuliaCy3P
N

Kocienski
Ir

PF6

Crabtree's Catalyst

olefination

followed

by

deprotection.

Selective reduction with Crabtree’s catalyst at the
C27-C28 position would deliver aplyronine A core
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6.1. The anticipated use of Crabtree’s catalyst to selectively reduce the C27-C28
allylic alcohol from coupling of 6.10 to 6.11 is key to the plan proposed in Figure
6.1.

(a) NaH, BuLi 88%; (b) (i) LiHMDS (1M THF), DMF/ HMPA (4:1) 60% (83% brsm) 12:1 (ii)
DIBAL-H, PhMe, -78 °C, 45 min; (c) (i) Ba(OH)2, THF:H2O (40:1), rt, 36 h, 84% (d) (R)-MeCBS,
BH3 SMe2, THF, -10 °C; NaH, MeI, THF, rt, 84%; (e) DIBAL, PhMe, 88% (f) pyridine, DessMartin periodinane, rt, 80%; (g) (EtO)2P(O)CH2CH=CHCO2Et, LiHMDS, THF, 72%; (h) 1N KOH,
EtOH, THF, 88%; (i) CSA (0.2 eq), MeOH, 74%; (j) 2,4,6-trichlorobenzoyl chloride, DMAP, Et3N,
PhMe, rt, 36 h, 66%

Scheme 6.1: Assembly of Aplyronine Macrolactone Core (Hong)
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Preparation of 6.4 was elaborated by Noshi3,5 and 6.5 (Scheme 5.3), was
discussed in Chapter 5. Substrates 6.4 and 6.5 were linked using a JuliaKocienski olefination,7-9 where Jacobsen’s solvent combination (DMF/HMPA)10,11
gave the best selectivity (E:Z = 12:1) in 60% yield, 83% based upon recovered
starting material. Epimerization of C19 methoxy group was not observed in the
crude product unless the base was added to the mixture of 6.4 and 6.5.
Reduction of C15 methyl ester with DIBAL-H afforded the desired aldehyde 6.7.
Addition of the dianion of β-ketophosphonate 6.3 to iodide 6.2 furnished a 1:1
mixture of diastereomeric C14 methyl groups in fragment 6.6. A Ba(OH)2
mediated

Horner-Wadsworth-Emmons

olefination

between

C5−C14

-

ketophosphonate 6.6 and the C15−C27 aldehyde 6.7 supplied the desired C5C27 segment 6.12 (70% yield) as an inseparable 12:1 mixture of (14E, 20E) and
(14E, 20Z), resulting from Julia-Kocienski product 6.7. The minor product (14E,
20Z) could be separated at a later stage of the synthesis.12 Chemo- and
stereoselective reduction of enone 6.12 gave the secondary alcohol in 84% yield,
which was treated with methyl iodide to afford methyl ether 6.13. The
regioselective ring opening of the p-methoxybenzylidene acetal with DIBAL-H at
0 ⁰C afforded intermediate 6.14 which was oxidized using Dess-Martin Periodane
to give aldehyde 6.8, which was immediately used in crude form for the next
reaction.

Horner-Wadsworth-Emmons

conditions

coupled

6.8

with

(EtO)2P(O)CH2CH=CHCO2Et 6.9 delivers dienoate 6.15 in 72% yield. Treatment
of dienoate 6.15 with 1N KOH gave carboxylic acid 6.16 in 88% yield. Selective
deprotection with 0.2 equivalents of (1S)-(+)-10-Camphorsulfonic acid exclusively
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furnished

(74%).

6.17

The

seco-acid

6.17

was

then

subjected

to

macrolactonization by using the Yamaguchi procedure to provide macrolactone
6.18.
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The sequence elucidated in Scheme 6.1 was devised to prepare the C28C34 fragment. The working hypothesis (Scheme 6.2), however, required
deprotection of the primary triisopropylsilyl ether at C27 of macrolactone 6.18 to
primary alcohol 6.19. Mitsunobu reaction followed by oxidation would likely
furnish phenyltetrazole sulfone 6.10. A Julia-Kocienski olefination between
sulfone 6.10 and lactone 6.11 would afford triene 6.20. Selective deprotection to
allyl alcohol 6.21 followed by hydrogenation in the presence of Crabtree’s
catalyst13 would deliver aplyronine core 6.1. It should be emphasized that
Scheme 6.2 could not be explored due to a lack of a substrate possessing the
C28-C34 landscape. The strategy illustrated in Scheme 6.2, as will be seen, had
deep implications for the unification of lactone triad 5.48.
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6.2: Implications of C32 des-Methyl Stereotriad
The synthetic sequence elucidated in Scheme 6.2 hinges on formation of
allylic alcohol 6.21. This key intermediate (6.21) contains olefins at 14E, 20E &
27E. Crabtree’s catalyst allows for selective reduction of 27E while leaving 14E &
20E intact. Coupling of stereotriad 5.48 to macrolactone 6.10 would afford triene
6.22. Triene 6.22 has an azidopivalate ester at the C29 position. The
azidopivalate is the precursor to the desired dimethylamino pivalate 6.23.
Unfortunately the presence of the azido ester eliminates the option of selective
hydrogenation with Crabtree’s catalyst. These facts eliminate Scheme 6.1 as a
viable option.

Figure 6.2: Repercussions of C29 Azidopivalate Stereotriad.
Constructing the C21-C34 Fragment
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As previously discussed, the fulcrum of synthetic rationale for the entire
coupling order of the aplyronine core target hinged upon there being an alcohol
available at the allylic position (C29) to allow for a directed iridium catalyzed
Crabtree hydrogenation in the presence of olefins at 14E & 20E to furnish the
single bond at C27-C28 without disturbing the spectator olefins (6.22). Previously
discussed limitations with the green C28-C34 fragment ultimately didn’t allow for
the Crabtree favorable landscape to be put into place. The most expedient
remedy would involve coupling red C21-C27 fragment 6.24 to C28-C34 green
stereotriad 5.48 by way of traditional olefination methodologies followed by
hydrogenation of the resulting olefin 6.26.

Figure 6.3: Constructing the C21-C34 Fragment

Utilization of the vinylsulfone polypropionate methodology to assemble the
aplyronine core reveals the importance of red C21-C27 fragment 6.24 as the key
to accessing macrolactone 6.1-des. Fragment 6.24 is undefined at C21 and the
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C23 oxygen. To complete construction of the aplyronine core the C21 & C23
positions of 6.24 must be defined in such a way so as to allow
olefination/reduction at the C27 position prior to installation of the C21 olefin. The
prevailing methodology used to construct the linear red stereotetrad 5.19
(Schemes 3.4 & 6.3) does not allow this (Figure 6.3).

(a) (i) O3, NaHCO3, EtOAc (ii) BH3, t-BuNH2 65%, 2 steps; (b) DCAD, PPh3,1-phenyltetrazole-5thiol 84%; (c) MeONHMe, iPrMgCl, 80%; (d) TESOTf, quant; (e) (i) DIBAL (ii) BH3 t-BuNH2
90%; (f) TIPSOTf, 2,6-lutidine 88%; (g) MCPBA, NaHCO3 71%

Scheme 6.3 (= 5.3): Synthesis of the C21-C27 Segment
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A cursory examination of 5.19 shows that the nature of the functional
groups on C21 & C27 must be inverted to allow the C27-C28 olefin to be formed
(6.25) and reduced (6.26) prior to construction of the aplyronine core..
Compounds 3.29, 5.12, & 5.17 can be important intermediates for the
achievement of a fully functionalized 6.24 fragment. An analysis and exploration
of efforts to construct a favorable linear C21-C27 fragment follows.

6.3: A Reexamination of the C21-C27 Fragment
Re-examination of the red fragment began with consideration of the
existing inventory of red stereotetrad linear intermediates (Figure 6.4). The Hong
archive contained intermediates directed towards linear stereotetrad 5.19. The
available compounds offered flexibility with respect to the construction of 6.24.
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Figure 6.4: Linear C21-C27 Stereotetrad Intermediates

The structures shown in Figure 6.4 show a definite bias in favor of JuliaKocienski precursors. 6.28 and 6.29 contain phenyltetrazole (PT) sulfide and
phenyltetrazole (PT) sulfone respectively at the favored C27 position. 6.30 and
6.33 have phenyltetrazole (PT) sulfone functionalities at C21, which is very
unfavorable. 6.31 and 6.32 have phenyltetrazole (PT) functionalities at C21
which may act as both olefination activators as well as transient protecting
groups. C21 and C23 of substrates 6.28, 6.29 and 6.30 are protected as paramethoxybenzylidine, providing the possibility of differentiation between C21 and
C23 upon deprotection. C27 of 6.30 and 6.32 are capped with a triisopropyl silyl
ether, utilized to differentiate existing t-butyldimethyl and triethylsilyl ethers. Initial
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investigation explored the efficacy of the intermediates in Figure 6.4 for obtaining
a practical linear C21-C27 stereotetrad.
The value of the compounds of Figure 6.4 is self-evident. Therefore the
first probe into procuring a useable C21-C27 linear section (Scheme 6.3) made
use of the most abundant compound of the inventory, 6.30. A model JuliaKocienski

reaction

with

benzaldehyde

delivered

styrene

6.34.

Global

deprotection with catalytic p-toluenesulfonic acid (p-TsOH) afforded triol 6.35.
The crude triol was selectively tosylated at the C27 primary alcohol with 1.1
equivalents of tosyl chloride (6.36). Treatment of 6.36 with p-TsOH in acetone
delivers acetonide 6.37 in quantitative yield. Reaction of 6.37 with 1-phenyl-5mercaptotetrazole in acetone at reflux delivered PT sulfide 6.38 in quantitative
yield. Multiple attempts at oxidation of sulfide 6.38 with ammonium molybdate
simply returned starting material. Time constraints, the small quantity of 6.30,
and possible need for optimization, contributed to the abandonment of this
pathway. Compound 6.39 was to be oxidized to sulfone 6.40, and after treatment
with p-TsOH to give diol 6.40. Ozonolysis of 6.40 would likely have delivered
lactol 6.41. Formation of ketal 6.42, should be effected with catalytic sulfuric acid
in methanol followed by silylether formation to have given 6.43.
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(a) PhCHO, NaHMDS, -78 °C,THF, 4hr, 71.7 %; (b) p-toluenesulfonic acid, MeOH, 86%; (c)
tosyl chloride (1.1 eq), pyr, 18 hrs, rt, 87%; (d) p-toluenesulfonic acid, Acetone, 100%; (e) 1Phenyl-5-mercaptotetrazole, K2CO3, acetone, reflux , 100%; (f) (NH4)6Mo7O24, H2O2, EtOH, rt;
(g) p-toluenesulfonic acid (2 eq), 4h, THF: H2O, reflux; (h) O3, DCM, MeOH, NaHCO3, -78 °C; (i)
H2SO4 (0.01%), MeOH; (j) R3Si, 1H-Imidizole, DMAP (cat), DMF, rt0 °C

Scheme 6.4: Transmutation of C21 Phenyltetrazole Sulfide 6.30

Compound 6.28 was a promising intermediate for the stated goals. C27
possesses the desired sulfide, and C21 is incorporated in the benzylidine.
Cerium ammonium nitrate (CAN) gives triol 6.46. Acetone with p-TsOH would
deliver acetonide 6.47. Ammonium molybdate oxidation should afford sulfone
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6.48 followed by silylether formation (6.49) to protect the C25 hydroxyl.
Unfortunately there was only 230 mg of 6.28 remaining in inventory and
subjecting such a small amount of valuable material to a 4-step sequence was
deemed impractical due to time constraints (Scheme 6.4).

(a) (NH4)2Ce(NO3)6, MeCN:H2O (9:1), rt; (b) MePhSO3H, Acetone (c) (NH4)6Mo7O24, H2O2, EtOH,
rt; (d) R3SiCl, NR3, DCM, rt

Figure 6.5: Expediency of Sulfide 6.28

Sulfide 6.32 (Figure 6.6) offers a unique opportunity to achieve a viable
C21-C27 linear vinylsulfone fragment. The phenyltetrazole sulfide may act as a
dormant functional group while the C27 can be transformed into a useable crosscoupling moiety. It is also a natural intermediate with respect to the prevailing
methodology (Schemes 3.4 and 5.3) so examination would provide valuable
information. It is worthy of note that triisopropylsilyl (TIPS) ether was very
resilient to cleavage. A global deprotection to triol (6.50) was required to remove
it, thus its use would have to be avoided in the future. Selective tosylation of 1°
alcohol at the C27 position would afford 6.51. Acetone and p-TsOH should yield
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acetonide 6.52. Finkelstein conditions would produce iodide 6.53. Phosphonium
iodide 6.54 can then undergo the Wittig olefination with 5.48 to obtain a C21-C34
27Z olefin.

(a) p-TsOH, MeOH; (b) tosyl chloride , C5H5N; (c) acetone, p-TsOH; (d) NaI, acetone, reflux
 rt; (e) NaHCO3, MeCN, PPh3, 8 h, reflux

Figure 6.6: Versatility of Sulfide 6.32

While the highly intricate fragments provided by Hong were not
themselves utilized to provide the desired C21-C27 motif, they provided direction
to future investigation, and proffered information as to the limitations of the
prevailing methodology.
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6.4: Further Evaluation Of C21-C27 Strategies
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Me2CO, reflux; (i) Ox, TBA (j) NaHMDS, THF

Scheme 6.5: Protecting Group Inversion Strategy

The Hong archive contained 14 grams of dienyl diad 3.26. Cyclic
vinylsulfone stereotetrad 6.55 was prepared as described in Scheme 3.4 without
treatment with t-butyldimethylsilyl triflate and camphor sulfonic acid in the final
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steps. Ozonolysis of 6.55 would produce lactone 6.56 and on subsequent
treatment with potassium hexamethyldisilazide and methyl iodide generate ketal
6.57. The methyl ester of 6.57 can be reduced to alcohol 6.58 and upon
treatment with tosyl chloride in pyridine provide tosylate 6.59. Displacement of
the 6.59 tosylate with phenyltetrazole thione affords sulfide 6.60; oxidation to
sulfone would give sulfone 6.61. Finally a Julia-Kocienski olefination between
6.61 and 5.48 would give the valuable C21-C34 olefin 6.62. The overall strategy
illustrated in Scheme 6.5 has become a working foundation for obtaining the
C21-C34 fragment.

Figure 6.7: Schreiber Ozonolysis Strategy

A variant of the traditional route could involve the innovation by
Schreiber14,15 of using acetic anhydride in the workup of the termini differentiated
ozonolysis intermediates. Decomposition of the molozide of 6.55 delivers
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Criegee zwitterion16 6.63 which is reduced to hydroperoxide 6.64. Treatment of
6.64 with acetic anhydride affords lactone 6.66 via perester 6.65. This tactic
would install the functionality at C27 needed to enable the coupling of C21-C27
and C28-C34 fragments.

Figure 6.8: Ozonolysis Of Diprotected Cyclic Vinylsulfone

A little explored strategy, is ozonolysis of the diprotected cyclic
vinylsulfone stereotetrads. From a strategic standpoint, the C23 and C25 hydroxy
groups must be differentiated so the desired macrolactone core can be
constructed. Under established methodology 5.19 achieved differentiation with a
triethylsilyl ether on C23 and t-butyldimethylsilyl ether on C25, 5.19 is formed via
lactone 5.12. Protection of C23 as the benzylester (6.67), methoxymethyl ether
(6.68), or THP (6.69) should prevent interference of the multifunctional substrate
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with the ozonolysis. Work-up with BH3•t–BuNH2 procures alcohols 6.72, 6.73,
and 6.77. Dimethylsulfide work-up, should give aldehydes 6.70, 6.74, and 6.75.
Treatment of these aldehydes with p-TsOH, in methanol would deliver ketals
6.71, 6.76 and 6.78. These post-ozonolysis termini differentiated fragments could
provide a solid foundation from which to achieve coupling of C21-C27 and C28C34 fragments that allow differentiation between the C23 and C25 alcohols.
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(a) NaHMDS, ((EtO)2HPO), THF; (b) NH3, MeOH, 24 hr, rt; (c) (i) O3,
AcOEt, NaHCO3; (ii) MeOH; (iii) Me2S.

Figure 6.8: Transposed Vinyl Phosphate Strategy

Transposition of the vinylsulfone to the vinyphosphonate was optimized by
Noshi,3,5 and ozonolysis of the vinyphosphonate explored by DuJardin.17 The
diprotected cyclic stereotetrad 6.67 is subjected to NaHMDS, ((EtO)2HPO), THF
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to obtain transposed vinyphosphonate 6.79. Cleavage of the benzylester using a
solution of methanol saturated with ammonia,18 would give alcohol 6.80.
Ozonolysis of 6.80 can then furnish desired lactone 6.81.

(a) NMO, 1.1 eq.,OsO4 cat., H2O/t-BuOH, 1:1,citric acid, 25 mol %; (b) (i)
Pb(OAc)4, MeOH (ii) NaHCO3, Me2CO, 14 h, reflux; (c) DiBAL-H; (d) TsCl,
pyr., rt, 24 hrs; (e) PhTezSH, K2CO3, Me2CO, reflux; (f) Oxone, MeOH, 2 d, rt;
(g) 5.48, NaHMDS, THF

Figure 6.10: Osmylation And Acyloin Cleavage Strategy

Diprotected cyclic vinylsulfone 6.67 could also be subjected to Sharpless
osmylation conditions.19 Acyloin 6.82 can then undergo oxidative cleavage on
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exposure to lead (IV) acetate in methanol to potentially furnish linear termini
differentiated C21-C27 fragment 6.83.
Reduction of 6.83 to terminal alcohol 6.84 followed by tosylation to 6.85
allows installation of terminal phenyltetrazole sulfide 6.86. Oxidation of 6.86 to
sulfone 6.8720 now allows for coupling via Julia-Kocienski conditions8 to afford
C21-C34 27Z olefin 6.88.
Of great interest was the concept of a self-immolating protecting group.
The azidopivalate utilized as a precursor for the dimethylamino ester at C32
shows potential self-immolative potential.
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Conditions: CH3P(O)(OC2H5)2, PhMe, rt; n-BuNH2, PhMe, rt; Base

Figure 6.11: Azidopivalate As A Self-Immolating Protecting Group

This concept was initially explored on indane azidopivalate ester 6.89
(Figure 6.11). Using Staudinger conditions with diethylphosphite, rather than the
traditional triphenylphosphine. Reduction of azide 6.89 by diethylphosphite leads
to intermediate 6.91 via 6.90. Cyclic intermediate 6.91 decomposes to nitrogen
and 6.92. The tautomer of 6.92 (6.92-taut) undergoes addition with n-butylamine
to afford 6.96; via 6.93, 6.94 and 6.95. Tautomerization of 6.96 to 6.96-taut
would be expected to decompose to alcohol 6.96 and 6.97.
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(a) LiHMDS (1M THF), DMF/ HMPA (4:1) 60% (83% brsm) 12:1; (b) Bu4N+ •F-, THF, AcOH (c)
TsCl, pyr., rt, 24 hrs; (d) PhTezSH, K2CO3, Me2CO, reflux; (e) Oxone, MeOH, 2 d, rt; (f)
NaHMDS, THF (g) HP(OEt)2, n-BuNH2, base (h) [Ir(cod)(PCy3)(py)]PF6, H2, CH2Cl2, 18 h, rt; (i)
4.83, (COCl)2, DMF, DMAP,TEA

Figure 6.12: Self-Immolative Azidopivalate Ester Strategy

The self-immolative potential of the C32 azidopivalate moiety could be
exploited so as to allow utilization of the original aplyronine core assembly
strategy (Scheme 6.1). Coupling fragments 6.4 and 6.5 with Julia-Kocienski
conditions was shown by Hong4 to give olefin 6.98. Selective deprotection21 of
the primary triisopropylsilyl ether may furnish primary alcohol 6.99. Tosylation
(6.100), sulfide formation (6.101), then oxidation would give sulfone 6.102. A
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second Julia-Kocienski coupling with 5.48 can deliver C15-C34 diolefin fragment
6.103 which could undergo self-immolation at the C32 azidopivalate to give allylic
alcohol

6.104.

Regioselective

hydrogenation

using

Crabtree’s

[Ir(cod)(PCy3)(py)]PF6 catalyst would give mono-olefin 6.105. Re-esterification of
6.105 with the in situ acid chloride of azido acid would produce the target olefin
azidopivalate 6.106.
Application of the vinylsulfone polypropionate methodology to the
construction of the aplyronine defined its limitations. An illustration of this is
shown in the osmylation of the vinylsulfone. The addition of citric acid to the
Upjohn

osmylation

conditions,

increased

the

versatility

of

vinylsulfone

methodology. The structure of the aplyronine core allows the question of
synthetic strategy to be answered. This was illustrated in the difficulty of dealing
with the order of coupling between the C15-C20, C21-C27 and C28-C34 linear
fragments. The structural requirements of the aplyronine core, lend themselves
to a number of synthetic strategies for assembling the C15-C34 fragment. The
richly-functionalized nature of the desired fragments forces analysis from multiple
angles, as seen with C28-C34 stereotriad 5.48 and illustrated in Figure 4.5.
Exploration of vinylsulfone chemistry was begun by the Fuchs research group in
197822-25 and after 35 years of investigation, vinylsulfone methodologies continue
to evolve.
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Appendix A: Experimental

General Procedures

All reagents purchased were used as received. Tetrahydrofuran (THF) and
diethyl ether were distilled from benzophenone ketyl. Benzene, toluene, and
methylene chloride (CH2Cl2) were distilled from calcium hydride. Acetonitrile
(CH3CN) and methanol were spectra-grade. Sodium sulfate (Na2SO4) was
anhydrous. All recrystallization, chromatographic, and workup solvents were
reagent

grade.

Progress

of

reactions

was

monitored

by

thin

layer

chromatography (TLC) using silica gel 60 F-254 plates (EM reagents, 0.25 mm).
The TLC plates were visualized with a UV lamp (254 nm) and/or with TLC
visualizing solutions activated with heat. The two commonly employed TLC
visualizing solutions were: (i) p-anisaldehyde solution (1350 mL absolute ethanol,
50 mL concentrated H2SO4, 37 mL p-anisaldehyde), and (ii) permanganate
solution (weight percents of 1% KMnO4 and 2% Na2CO3 in water). 1H NMR and
13

C NMR spectra were recorded on Varian Inova 300 (300 MHz), Bruker DRX

500 (500 MHz), Varian Inova 600 (600 MHz), Bruker AV 800 (800 MHz). NMR
spectra were determined in chloroform-d1 (CDCl3), dimethylsulfoxide (DMSO-d6),
benzene-d6 (C6D6) or acetone-d6 solution and reported in parts per million (ppm)
from the residual chloroform (7.27 ppm and 77.0 ppm), DMSO (2.50ppm and
39.52ppm), benzene (7.16 ppm and 128.0 ppm) and acetone (2.05 ppm and
29.9/ 206.7 ppm) standard respectively. Peak multiplicities in 1H-NMR spectra,
when reported, are abbreviated as s (singlet), d (doublet), t (triplet), q (quartet), p
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(quintet), m (multiplet), ap (apparent), and br (broad). Mass spectra were
determined by the Purdue University campus wide mass spectrometry facility.

To a cooled 0 °C solution of 2-(phenylsulfonyl)cyclohepta-1,3-diene
3.5 (40 g, 171 mmol), Ammonium acetate (2.63 g, 34.1 mmol), and (R,R)-(-)N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminomanganese(III)
chloride (1.627 g, 2.56 mmol) in MeOH (Ratio: 1.000, Volume: 285 mL) : DCM
(Ratio: 1.000, Volume: 285 mL) was added pre-cooled aqueous hydrogen
peroxide 30% (17.44 mL, 171 mmol) in four portions during 40 minutes. The
mixture was stirred at 0 ºC and the reaction was monitored by TLC. After the
reaction had reached completion, the mixture was diluted with ether and extra
H2O2 was added to decompose any remaining catalyst, and transferred into a
separatory funnel containing water. The organic layer was washed with water
and brine. The organic layer was separated, dried over Na2SO4, and
concentrated. The crude material was used in the next step w/o further
purification. The residue was analyzed by 1H NMR and found to be highly pure,
yielding (1S,7S)-2-(phenylsulfonyl)-8-oxabicyclo[5.1.0]oct-2-ene (38.0 g, 152
mmol, 89 % yield). 1H NMR (500 MHz, Chloroform-d)  7.93 – 7.86 (m, 2H), 7.64
– 7.55 (m, 1H), 7.55 – 7.49 (m, 2H), 7.37 (ddd, J = 7.5, 3.3, 1.3 Hz, 1H), 3.67 (dd,
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J = 4.4, 1.3 Hz, 1H), 3.41 (td, J = 4.3, 2.6 Hz, 1H), 2.58 – 2.47 (m, 1H), 2.24 (ddt,
J = 19.0, 9.4, 3.7 Hz, 1H), 2.15 – 1.97 (m, 2H), 1.67 – 1.54 (m, 2H).

2-(Phenylsulfonyl)-1,3-cycloheptadiene (2.2): To a 12-L 3-neck
round bottom flask equipped with a mechanical stirrer, heating mantle,
Dean-Stark trap and condenser, were added cycloheptanone (1.0 kg,
8.92 mol), 1.05 equivalents benzenethiol (1.06 kg), and 10 wt%
Montmorillonite KSF (100 g) in toluene (2.2 L) and refluxed for 24 hours. After the
reaction, the resulting vinyl sulfide mixture was cooled to room temperature and
then filtered through a Celite® (100 g) pad and the pad was washed with toluene
(2.2 L). A sample of the toluene mixture was dried via spin-evaporation to an
amber syrup. 1H NMR (600 MHz, Chloroform-d)  7.33 (dd, J = 8.2, 1.5 Hz, 2H),
7.30 (dd, J = 8.6, 6.7 Hz, 2H), 7.22 – 7.19 (m, 1H), 6.17 (t, J = 6.6 Hz, 1H), 2.39
– 2.34 (m, 3H), 2.24 – 2.18 (m, 3H), 1.79 – 1.72 (m, 3H), 1.59 – 1.53 (m, 6H).

The solution was transferred to a 22-L 3-neck round bottom flask
S

equipped with a mechanical stirrer, addition funnel, thermometer, and
Br

water bath, 1.0 equiv sodium bromide (918 g), 1.0 equiv 2 M H3PO4
solution (4.46 L), 0.01 equiv 1M aqueous Na2WO4·2H2O (89 mL), and

3.3

0.01 equiv 1M aqueous PhPO(OH)2 (89 mL) were added and stirred in
the water bath for 30 minutes. With vigorous stirring, 1.0 equiv 30 wt% H2O2 (857
mL) was slowly added with the addition funnel for 3 hours. The reaction
temperature was below 25 °C and the bath temperature was in the range of 15 to
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18 °C. After one more hour of stirring, the aqueous layer was removed, and the
organic layer was washed with 2 M Na2SO3 (1 L) and 2 M H3PO4 (1 L) to give a
crude mixture of 3.3. To the solution of 3.3 was added 0.01 equiv 1M aqueous
Na2WO4·2H2O (89 mL), 0.01 equiv 1M aqueous PhPO(OH)2 (89 mL), 0.01equiv
PTC (0.5M solution in toluene, 180 mL) and stirred in the water bath for 30
minutes. 2.0 equiv 30 wt% H2O2 (1.7 L) was added slowly with an addition funnel
for 2.5 hours. After stirring vigorously in the water bath for 15 hours, brine (1 L)
was added and stirred for 1 minute. The aqueous layer was removed. 1H NMR
(600 MHz, Chloroform-d)  7.49 (dd, J = 7.5, 1.6 Hz, 1H), 7.34 (d, J = 7.4 Hz,
3H), 7.30 (td, J = 7.5, 5.6 Hz, 3H), 7.22 (td, J = 7.0, 1.9 Hz, 1H), 6.42 (ddd, J =
8.2, 5.0, 1.2 Hz, 1H), 4.77 – 4.71 (m, 1H), 2.53 – 2.43 (m, 1H), 2.37 (dtd, J =
17.7, 7.7, 2.4 Hz, 1H), 2.29 (dddd, J = 16.1, 11.4, 4.9, 2.5 Hz, 1H), 2.17 – 2.06
(m, 2H), 1.97 (ddq, J = 13.1, 6.5, 3.2 Hz, 1H), 1.87 (ddd, J = 13.9, 6.8, 3.5 Hz,
1H), 1.82 (ddt, J = 14.8, 12.1, 3.0 Hz, 1H), 1.71 (qd, J = 5.7, 4.8, 1.9 Hz, 1H),
1.48 (dtt, J = 13.5, 10.8, 2.6 Hz, 1H).
To the toluene solution of 3.3 were added 0.8 equivalents
O
N

O

S

pyridine (580 mL) and water (8.92 L) and with stirring, heated
from room temperature to 60 °C for 2 hours. After removal of

Br
3.4

the organic layer, the aqueous layer was washed with ethyl

acetate (2 x 1 L) and then hexane (1 L) while the solution temperature
maintained about 60 °C. To remove the insoluble solid, the warm aqueous layer
was filtered through a small glass filter into a 22-L 3-neck round bottom flask,
equipped with a mechanical stirrer. Cooling to room temperature gave a white
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solid suspension of 3.4. 1H NMR (600 MHz, Chloroform-d)  9.50 (d, J = 6.1 Hz,
2H), 8.40 (t, J = 7.7 Hz, 1H), 8.05 (t, J = 7.0 Hz, 2H), 7.91 (dd, J = 7.4, 5.4 Hz,
1H), 7.87 – 7.82 (m, 2H), 2.91 (ddt, J = 15.3, 10.0, 4.9 Hz, 1H), 2.84 – 2.70 (m,
2H), 2.28 (ddt, J = 14.7, 11.3, 3.4 Hz, 1H), 1.85 (dq, J = 12.7, 6.9, 5.6 Hz, 1H),
1.80 – 1.64 (m, 2H), 1.45 (ddd, J = 19.6, 8.7, 5.3 Hz, 1H).

To the white solid suspension of 3.4 were added 0.1 wt% of seed
O
O

S

crystals of 3.5 (1 g) and 0.7 equiv 1,4-diazabicyclo[2.2.2]octane
(DabcoTM, 701 g). After stirring for 36 hours at room temperature, 2 N

3.5

HCl (4.0 L) was added, filtered through a large glass filter and rinsed

with water (5 L). It was dried to content weight in a dying oven under vacuum at
40 °C to give a pure and white solid (3.5, 1.11 kg, 53% yield over 5 steps from
cycloheptanone, 98% purity by HPLC). mp: 61-62 °C (lit. 57-58 °C); 1H NMR (600
MHz, Chloroform-d)  7.92 – 7.87 (m, 2H), 7.66 – 7.60 (m, 1H), 7.55 (td, J = 7.7,
7.3, 1.4 Hz, 2H), 7.33 – 7.30 (m, 1H), 6.10 – 6.02 (m, 2H), 2.62 – 2.57 (m, 2H),
2.35 (qd, J = 5.1, 2.3 Hz, 2H), 1.92 – 1.85 (m, 2H).
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To a cooled 0 °C solution of 2-(phenylsulfonyl)cyclohepta-1,3-diene
3.5 (58 g, 248 mmol), Ammonium acetate (3.82 g, 49.5 mmol), and (S,S)-(+)N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminomanganese(III)
chloride (3.93 g, 6.19 mmol) in MeOH (Ratio: 1.000, Volume: 413 mL) : DCM
(Ratio: 1.000, Volume: 413 mL) was added pre-cooled aqueous hydrogen
peroxide 30% (25.3 mL, 248 mmol) in four portions during 40 minutes. The
mixture was stirred at 0 ºC and the reaction was monitored by TLC. After the
reaction had reached completion, the mixture was diluted with DCM (Ratio:
1.000, Volume: 413 mL) and transferred into a separatory funnel containing
water. The organic layer was washed with water and brine. The organic layer
was separated, dried over Na2SO4, and concentrated. The crude material was
used in the next step without further purification. The residue was analyzed by 1H
NMR and

found to be highly pure, yielding (1R,7R)-2-(phenylsulfonyl)-8-

oxabicyclo[5.1.0]oct-2-ene (62.0 g, 248 mmol, 100 % yield) 1H NMR (600 MHz,
Chloroform-d) δ 7.93 – 7.88 (m, 2H), 7.62 (t, J = 7.4 Hz, 3H), 7.54 (t, J = 7.7 Hz,
2H), 7.41 – 7.37 (m, 1H), 4.10 (q, J = 7.1 Hz, 1H), 3.69 (d, J = 4.3 Hz, 1H), 3.43
(td, J = 4.3, 2.4 Hz, 1H), 2.59 – 2.49 (m, 1H), 2.26 (ddt, J = 18.9, 9.9, 3.6 Hz,
1H), 2.12 (dddd, J = 14.9, 6.7, 4.1, 1.8 Hz, 3H), 2.08 – 2.00 (m, 2H), 1.61 (dtt, J =
14.7, 10.7, 3.6 Hz, 2H), 1.24 (t, J = 7.1 Hz, 1H).
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A

solution

of

crude

triethyl((1R,2S)-2-methyl-5-(phenylthio)cyclohepta-3,5-

dienyloxy)silane (5.38 g, 15.52 mmol) in toluene, (155 mL) was stirred under air
to give a brown solution. Sequential addition of Sodium tungstate dihydrate
(0.310 mL, 0.310 mmol), phenylphosphonic acid (0.31 0

mL,

0.310

mmol),

methyltrioctylammonium hydrogen sulfate (0.621 mL, 0.310 mmol), and
hydrogen peroxide 30% (3.17 mL, 31.0 mmol), was followed by vigorous stirring
at 25 °C. After 4 hr the reaction was judged complete by TLC and the mixture
was transferred to a separatory funnel, brine (200 mL) was added. The aqueous
layer was extracted with ether (2×100 mL) and the combined organic layers were
washed with saturated Na2SO3 solution, dried over Na2SO4 and concentrated via
rotary evaporation to give triethyl((1R,2S)-2-methyl-5-(phenylsulfonyl)cyclohepta3,5-dienyloxy)silane (4.93 g, 13.0 mmol, 84 % yield) as a light yellow viscous oil
Use appropriate number of sig figs throughout. This material was used in the
next step w/o further purification. 1H NMR (600 MHz, Chloroform-d)  7.85 – 7.82
(m, 2H), 7.60 – 7.56 (m, 1H), 7.50 (dd, J = 8.4, 7.1 Hz, 2H), 7.07 (ddd, J = 6.4,
4.9, 1.4 Hz, 1H), 6.00 (d, J = 11.8 Hz, 1H), 5.90 (dd, J = 11.8, 6.5 Hz, 1H), 4.05
(ddd, J = 8.8, 4.3, 3.1 Hz, 1H), 3.40 (dt, J = 11.0, 3.3 Hz, 0H), 2.69 – 2.55 (m,
3H), 2.42 (qd, J = 7.9, 5.5 Hz, 1H), 0.96 (d, J = 7.1 Hz, 3H), 0.91 (t, J = 8.0 Hz,
9H), 0.55 (q, J = 7.9 Hz, 6H).
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A solution of trimethylaluminum 25% in hexanes (40.3 mL, 101
mmol) in dry methylene chloride (105 mL) was cooled to -20 oC for 30 minutes
then water (0.311 mL, 17.28 mmol) was very carefully added dropwise over 30
minutes. The dry ice bath was removed and the reaction stirred for 1h. Solid
(1S,7S)-2-(phenylsulfonyl)-8-oxabicyclo[5.1.0]oct-2-ene (2.5) (7.21 g, 28.8 mmol)
was added in portions and the reaction was stirred at 25 °C for 40 minutes.
Reaction was checked for completion using TLC (50% ethyl acetate/hexanes)
then the reaction mixture was cooled again to -40 °C for 30 minutes. Upon
completion the contents were carefully poured into excess HCl

(aq)/

crushed ice

mixture and allowed to warm to room temperature. The organic phase was
separated, washed with brine (1 L), dried over Na2SO4, and then was
concentrated via rotary evaporation to afford crude yellowish oil (dr 10:1).
Purification by flash column chromatography (20% ethyl acetate/hexanes)
afforded

(1S,2R)-2-methyl-3-(phenylsulfonyl)cyclohept-3-enol

(7.59

g,

27.1

mmol, 94 % yield) as a colorless oil. 1H NMR (500 MHz, Chloroform-d)  7.90 –
7.84 (m, 2H), 7.62 – 7.57 (m, 1H), 7.55 – 7.49 (m, 2H), 7.34 (ddd, J = 9.6, 4.1,
1.3 Hz, 1H), 3.79 (qd, J = 4.9, 1.9 Hz, 1H), 2.94 – 2.84 (m, 1H), 2.50 – 2.40 (m,
1H), 2.24 (dddd, J = 15.7, 12.8, 4.2, 2.7 Hz, 1H), 1.98 – 1.91 (m, 1H), 1.87 – 1.78
(m, 1H), 1.75 – 1.65 (m, 1H), 1.57 – 1.46 (m, 2H), 1.22 (d, J = 13.8 Hz, 1H), 0.88
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(d, J = 7.3 Hz, 3H);

13

C NMR (126 MHz, CDCl3)  143.96, 142.26, 138.70,

133.18, 128.99, 128.33, 69.38, 39.70, 31.33, 27.33, 18.20, 15.37.
show stereo of sulfone below

A solution of (1S,2R)-2-methyl-3-(phenylsulfonyl)cyclohept3-enol (10.07 g, 37.8 mmol) in THF (95 mL) was cooled to -78 °C for 30 min
then sodium bis(trimethylsilyl)amide, (60.5 mL, 121 mmol) was added dropwise
over 10 minutes to give a clear yellow solution that eventually turns into deep red
clear solution. The dry ice bath was removed and the mixture was stirred at 25
°C for 4 hr to give a bright orange suspension. Reaction is checked for complete
dianion formation using TLC (50% ethyl acetate/hexane). Phenyl disulfide (8.25
g, 37.8 mmol) was added as a solid at 25 °C to the reaction mixture where the
orange suspension dissolves and reforms immediately. After stirring for 1 hr,
reaction was quenched with aqueous hydrochloric acid (182 mL, 250 mmol) and
diluted with ether (182 mL, 1750 mmol). After discarding aqueous phase,
hydrochloric acid (182 mL, 250 mmol) was added and the mixture was stirred for
1 hr. After discarding aqueous phase the organic phase was separated, washed
with brine, and dried over Na2SO4 for 2h. Concentration of the organic phase via
rotary

evaporation

afforded

(1S,2R)-2-methyl-3-(phenylsulfonyl)-5-
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(phenylthio)cyclohept-4-enol (14.16 g, 37.8 mmol, 100 % yield) as a brown oil.
1

H NMR (600 MHz, Chloroform-d)  7.68 (d, J = 7.7 Hz, 2H), 7.61 (t, J = 7.5 Hz,

1H), 7.48 (t, J = 7.7 Hz, 2H), 7.34 (dd, J = 5.1, 2.0 Hz, 3H), 7.27 (dd, J = 6.7, 2.7
Hz, 2H), 5.31 (d, J = 6.1 Hz, 1H), 4.52 (d, J = 6.1 Hz, 1H), 3.93 (q, J = 3.6 Hz,
1H), 2.77 (dd, J = 15.8, 12.8 Hz, 1H), 2.69 – 2.61 (m, 1H), 1.78 – 1.69 (m, 2H),
1.59 (dt, J = 14.9, 5.0 Hz, 1H), 1.04 (d, J = 7.0 Hz, 3H).

13

C NMR (126 MHz,

CDCl3)  142.79, 138.64, 133.81, 133.42, 131.66, 129.30, 129.00, 128.56,
128.42, 116.68, 72.49, 62.45, 35.59, 26.52, 26.29, 12.75.

stereo of sulfone?

A 3-neck 1 liter flask was flame dried under dry N2
atmosphere then was charged with a solution of thoroughly dried (1S,2R)-2methyl-3-(phenylsulfonyl)-5-(phenylthio)cyclohept-4-enol (11.39 g, 30.4 mmol) in
anhydrous dichloroethane, (Volume: 76 mL) at 25 °C. The reaction was cooled to
0 oC then solid imidazole (4.55 mL, 33.5 mmol) was added followed slow stream
addition of chlorotriethylsilane (5.67 mL, 33.5 mmol) over 10 minutes. After the
reaction shows yellowish precipitation of imidazolium hydrochloride, stirring was
continued for 1-2 hours at 0 to 25 oC. The reaction was checked for completion
by TLC (50% ethyl acetate/hexane) then was filtered over a celite pad under
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vacuum. The pad was washed with DCE (2 x 100 mL), and the combined organic
phases were concentrated via rotary evaporation to afford crude triethyl
(((1S,2R)-2-methyl-3-(phenylsulfonyl)-5-(phenylthio)cyclohept-4-en-1yl)oxy)silane (14.56 g, 29.8 mmol, 98 % yield) as an amber oil that did not require
further purification. An analytical sample was obtained via FCC (10% ethyl
acetate/hexane) as a clear yellow oil. TLC (50% ethyl acetate/hexane) Rf 0.9; 1H
NMR (600 MHz, Chloroform-d)  7.72 (d, J = 7.7 Hz, 2H), 7.61 (t, J = 7.5 Hz, 1H),
7.50 (t, J = 7.6 Hz, 2H), 7.37 – 7.30 (m, 5H), 5.53 (d, J = 6.0 Hz, 1H), 4.57 (d, J =
6.0 Hz, 1H), 3.87 – 3.79 (m, 1H), 2.82 (dd, J = 15.4, 12.7 Hz, 1H), 2.47 (dt, J =
11.5, 5.8 Hz, 1H), 2.04 (d, J = 11.6 Hz, 0H), 1.77 – 1.65 (m, 2H), 1.43 (dt, J =
14.8, 5.5 Hz, 1H), 1.04 (d, J = 7.0 Hz, 3H), 0.89 (t, J = 7.9 Hz, 9H), 0.51 (q, J =
8.0 Hz, 6H);

13

C NMR (CDCl3, 75 MHz)  142.4, 138.8, 133.5, 133.3, 132.1,

129.3, 129.0, 128.5, 128.3, 117.4, 72.8, 62.6, 36.3, 27.5, 26.4, 12.6, 6.8, 4.7.

triethyl(((1S,2R)-2-methyl-3-(phenylsulfonyl)-5(phenylthio)cyclohept-4-en-1-yl)oxy)silane (14.56 g, 29.8 mmol) and N,Ndiisopropylethylamine (18.21 mL, 104 mmol) was dissolved in dry methylene
chloride (149 mL) then was transferred to a 3-neck 1 L flask under Ar
atmosphere. The flask was cooled to -78 °C until the internal temperature
became at least -72 °C then was added trimethylaluminum 25% in Hexanes
(27.4 mL, 68.5 mmol). The acetone/ dry ice bath was removed, and the reaction
was allowed to warm to 25 ºC then stirring was continued for at least 2 hours.
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The reaction was checked for completion via TLC (20% ethyl acetate/ hexane)
then the reaction contents were transferred to a suspension of 5%(aq) HCl (1.3 L,
10 eq) / crushed ice. The mixture is added to a separatory funnel and washed
with deionized water. Methylene chloride was removed via spin-evaporation and
the remaining aqueous mixture was extracted with toluene (150 mL). The wet
toluene layer was filtered through a celite pad to provide a filtrate of
triethyl(((1S,2S)-2-methyl-5-(phenylthio)cyclohepta-3,5-dien-1-yl)oxy)silane
(10.32 g, 29.8 mmol, 100 % yield). The crude filtrate was subjected to the Noyori
oxidation without further purification.

A

solution

of

triethyl(((1S,2S)-2-methyl-5-

(phenylthio)cyclohepta-3,5-dien-1-yl)oxy)silane (10.32 g, 29.8 mmol) in toluene
(298 mL), was stirred under air to give a brown solution. The solution was treated
with sequential addition of aqueous sodium tungstate dihydrate (0.595 mL, 0.595
mmol), aqueous phenylphosphonic acid (0.595 mL, 0.595 mmol), aqueous
methyltrioctylammonium hydrogen sulfate (1.191 mL, 0.595 mmol), and
hydrogen peroxide 30% (6.08 mL, 59.5 mmol), was followed by vigorous stirring
at 25 °C. After 4 hr the reaction was judged complete by TLC and the mixture
was transferred to a separatory funnel, brine (200 mL) was added. The aqueous
layer was extracted with ether (2×100 mL) and the combined organic layers were
washed with saturated Na2SO3 solution, dried over Na2SO4 and concentrated via
rotary

evaporation

to

give

triethyl(((1S,2S)-2-methyl-5-
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(phenylsulfonyl)cyclohepta-3,5-dien-1-yl)oxy)silane (11.27 g, 29.8 mmol, 100 %
yield) as an orange oil triethyl(((1S,2S)-2-methyl-5-(phenylsulfonyl)cyclohepta3,5-dien-1-yl)oxy)silane (11.27 g, 29.8 mmol, 100 % yield) as a light yellow
viscous oil. 1H NMR (600 MHz, Chloroform-d)  7.89 – 7.85 (m, 2H), 7.62 – 7.57
(m, 1H), 7.52 (ddd, J = 8.1, 6.7, 1.2 Hz, 2H), 7.21 (ddd, J = 7.0, 5.6, 1.5 Hz, 1H),
6.05 (dt, J = 11.7, 1.6 Hz, 1H), 5.85 (dd, J = 11.8, 5.2 Hz, 1H), 3.83 (ddd, J = 7.2,
6.2, 3.2 Hz, 1H), 2.67 – 2.58 (m, 1H), 2.53 (ddd, J = 16.6, 5.7, 3.1 Hz, 1H), 2.34 –
2.26 (m, 1H), 1.02 (d, J = 7.1 Hz, 3H), 0.93 (t, J = 8.0 Hz, 9H), 0.61 – 0.54 (m,
6H). This material was used in the next step without further purification.

A 3-neck 3 L flask was equipped with an overhead
mechanical stirrer, a thermometer, and an argon inlet triethyl(((1S,2S)-2-methyl5-(phenylsulfonyl)cyclohepta-3,5-dien-1-yl)oxy)silane (3.000 g, 7.92 mmol) was
dissolved in acid-free methylene chloride (60 mL) then was transferred to the
flask, and cooled to 0 °C, 0.132 M. After stirring for 10 minutes, (S,S)-(+)-N,N'bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminomanganese(III) chloride
(0.252 g, 0.400 mmol), 4-(3-Phenylpropyl)pyridine N-oxide (0.510 g, 2.38 mmol)
were sequentially added. Cold sodium hypochlorite 10.8% (15.49 mL, 20.60
mmol) was freshly mixed with cold 0.05 M sodium dihydrogen phosphate(aq) (37
mL, 1.86 mmol), and the mixture was poured as a slow but continuous stream to
the cold reaction. After 2 hours at 0 °C, the reaction progress was checked via
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TLC (30% ethyl acetate/hexane). It is noted that the stirring needs to be stopped
until phase separation occurs, then the TLC sample must be withdrawn from the
bottom organic layer via a Pasteur pipette. After completion, hexane (3x 60 mL)
was added to the reaction, and stirring was continued for 1-2 hours at 25 oC.
Ideally, Mn-salen catalyst precipitates as brown aggregates leaving a clear pale
yellow solution above. If necessary, additional 10% aq. NaOCl (0.5 equiv.) is
added at 25 oC in order to create a minor exotherm thereby destroying the
residual Mn-salen catalyst, and preparing it for precipitation. Filtration over
Whatman 1 filter paper provides a clear yellow solution. Removal of solvents via
rotary evaporation afforded triethyl(((1R,2S,3S,7R)-2-methyl-6-(phenylsulfonyl)8-oxabicyclo[5.1.0]oct-5-en-3-yl)oxy)silane (3.2 g, 8.11 mmol, 100 % yield) as a
dark brown oil that was sufficiently pure as judged by NMR for the next synthetic
step. 1H NMR (500 MHz, Chloroform-d) δ 7.91 – 7.88 (m, 2H), 7.66 – 7.61 (m,
1H), 7.58 – 7.52 (m, 2H), 7.31 (ddd, J = 8.8, 3.8, 1.3 Hz, 1H), 3.69 (dd, J = 4.2,
1.2 Hz, 1H), 3.33 (td, J = 9.2, 2.0 Hz, 1H), 3.26 (dd, J = 4.2, 2.9 Hz, 1H), 2.56
(ddd, J = 17.1, 8.8, 2.0 Hz, 1H), 2.44 (ddd, J = 17.2, 9.2, 3.9 Hz, 1H), 2.25 – 2.14
(m, 1H), 1.15 (d, J = 7.0 Hz, 3H), 0.92 (t, J = 7.9 Hz, 9H), 0.61 – 0.53 (m, 6H).
13

C NMR (126 MHz, CDCl3) δ 141.20, 139.92, 139.37, 133.48, 129.17, 127.96,

70.83, 60.41, 52.18, 42.13, 38.13, 16.51, 6.74, 4.71.
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HO

S
O O N
N

O
Si

3.28

condenser,

and

A 3-neck 1L flask was fit with an overhead reflux
two

septa.

Crude

triethyl(((1R,2S,3S,7R)-2-methyl-6-

(phenylsulfonyl)-8-oxabicyclo[5.1.0]oct-5-en-3-yl)oxy)silane (3.27) (7.08 g, 17.94
mmol)

was dissolved in dry toluene

(90 mL), then was transferred to the

reaction flask. 3,5-dimethylpyrazole (1.90 g, 19.74 mmol) was added, then the
reaction was heated at 50-60 oC for 1 hour and/ or until TLC shows consumption
of starting material. The reaction was cooled to 25 oC then washed with crushed
ice/ brine (150 mL)/ 5% aqueous HCl (39 mL, 0.8 equiv.). The aqueous phase
was discarded, and then the organic phase was washed with brine, and dried
over Na2SO4 for 3 hours. The toluene was removed via spin-evaporation to
provide a crude semi-solid. The semi-solid was purified by silica-gel
chromatography (9:1 toluene : tetrahydrofuran) to furnish (1R,4S,6S,7S)-4-(3,5dimethyl-1H-pyrazol-1-yl)-7-methyl-3-(phenylsulfonyl)-6((triethylsilyl)oxy)cyclohept-2-enol (6.69 g, 13.64 mmol, 76 % yield) 1H NMR (600
MHz, Chloroform-d)  7.80 (dd, J = 8.7, 0.9 Hz, 1H), 7.58 (dt, J = 8.5, 1.1 Hz,
2H), 7.48 – 7.44 (m, 1H), 7.33 (tt, J = 7.4, 0.9 Hz, 2H), 7.01 – 6.96 (m, 1H), 5.50
(s, 1H), 5.37 (dd, J = 5.3, 2.9 Hz, 1H), 4.40 (ddd, J = 10.9, 8.7, 2.0 Hz, 1H), 4.00
(td, J = 10.5, 2.4 Hz, 1H), 2.36 (t, J = 0.8 Hz, 1H), 2.14 (ddd, J = 14.4, 5.3, 2.5
Hz, 1H), 2.09 (d, J = 0.8 Hz, 3H), 2.09 – 2.03 (m, 2H), 1.98 (d, J = 0.9 Hz, 3H),
1.83 – 1.75 (m, 1H), 1.66 (s, 1H), 1.25 (dd, J = 6.9, 0.9 Hz, 3H), 1.02 (td, J = 8.0,
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0.9 Hz, 2H), 0.82 (td, J = 8.0, 0.9 Hz, 9H), 0.41 (qdd, J = 8.1, 3.6, 1.0 Hz, 6H);
13

C NMR (126 MHz, CDCl3)  146.94, 146.28, 140.07, 138.79, 138.48, 132.83,

128.43, 126.98, 105.22, 68.71, 67.22, 50.43, 45.80, 44.17, 16.42, 12.71, 10.44,
6.59, 4.59.

A dry 100 mL RB flask was charged with a solution of
(1R,2R,6S,7S)-2,7-dimethyl-3-(phenylsulfonyl)-6-((triethylsilyl)oxy)cyclohept-3enol (0.360 g, 0.877 mmol) in dry methylene chloride (10 mL), then the solution
was cooled to 0 °C. After 15 min, 2,6-lutidine (0.102 mL, 0.877 mmol) was
added dropwise, then

t-butyldimethylsilyl trifluoromethansulfonate (0.202 mL,

0.877 mmol) was added dropwise via syringe. The reaction was stirred at 0 oC for
30-60 minutes, then methanol (0.177 mL, 4.38 mmol) was added dropwise, and
stirring was continued for another 30 minutes. The reaction was diluted with 5%
HCl(aq), washed, then the aqueous layer was discarded after neutralization. The
organic layer was transferred to another flask, cooled to 0

o

C, and then

camphorsulfonic acid (0.102 g, 0.438 mmol) was added. After stirring at 0 oC for
2 hours, the reaction was neutralized carefully with sat aq. NaHCO3, and then
washed with saturated NaHCO3(aq). The organic layer was then washed with
brine, and then dried over Na2SO4 for 6 hours. 1H NMR (500 MHz, Chloroform-d)
 7.88 – 7.83 (m, 2H), 7.62 – 7.57 (m, 1H), 7.56 – 7.49 (m, 3H), 7.13 (t, J = 6.2
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Hz, 1H), 3.88 (ddd, J = 8.3, 6.5, 2.0 Hz, 1H), 3.76 (dd, J = 5.6, 3.6 Hz, 1H), 2.74
(ddd, J = 16.8, 6.1, 2.1 Hz, 1H), 2.66 – 2.58 (m, 1H), 2.56 – 2.50 (m, 1H), 2.11 –
2.02 (m, 1H), 2.00 (d, J = 0.6 Hz, 1H), 1.19 (d, J = 7.5 Hz, 3H), 1.11 (d, J = 7.3
Hz, 3H), 0.96 (t, J = 8.0 Hz, 2H), 0.78 (s, 9H), 0.63 – 0.55 (m, 2H), -0.20 (s, 3H), 0.36 (s, 3H).

To a solution of diisopropylamine (0.031 mL, 0.218 mmol) in
anhydrous tetrahydrofuran and hexamethylphosphoramide (HMPA) (5:2) at - 20
°C a commercially available n-butyllithium solution (0.091 mL, 0.228 mmol) was
added under an argon atmosphere at which point the diphenyl-2-pyridylmethane
indicator turned red remained that way briefly and faded back to pale yellow.
Additional n-butyllithuim (0.0455 mL, 0.114 mol) was added and the indicator
remained red. The resulting solution was stirred for ca. 30 min and then a
solution

of

(bromomethyl)dimethyl((1R,2S)-2-methyl-5-(phenylsulfonyl)

cyclohept-3,5-dienyloxy)silane (0.0411 g, 0.099 mmol) in THF (4.12 mL) was
added with a syringe. An orange color was observed. At -35 °C the indicator
turned red and a TLC indicated no starting material remaining. The THF was
removed via spin-evaporation and the HMPA concentrate was partitioned
between ethyl acetate (100 mL) and aqueous HCl (100 mL). The ethyl acetate
portion was washed with HCl (2 × 100 mL), deionized water (1×100 mL) and
brine (1×100 mL). The ethyl acetate was removed by spin evaporation. The
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crude oil was purified via flash chromatography (4:1 hexanes: ethyl acetate) to
yield

(S)-2,7-dimethyl-4-(phenylsulfonyl)cyclohepta-1,3,5-triene

(0.020 g,

0.077 mmol 78 %) as a white semi-solid. 1H NMR (600 MHz, Chloroform-d) 
7.89 – 7.83 (m, 2H), 7.68 (s, 1H), 7.57 (t, J = 7.4 Hz, 1H), 7.49 (t, J = 7.7 Hz, 2H),
6.38 (d, J = 9.5 Hz, 1H), 5.31 (dd, J = 9.5, 5.5 Hz, 1H), 5.09 (d, J = 5.3 Hz, 1H),
1.98 (d, J = 1.5 Hz, 3H), 1.58 (q, J = 6.5 Hz, 1H), 1.23 (d, J = 7.0 Hz, 3H).

Triethyl((1R,2R)-2-methyl-3-(phenylsulfonyl)-5(phenylthio)cyclohept-4-enyloxy)silane (3.77 g, 7.70 mmol)

and

N,N-

diisopropylethylamine (4.71 mL, 26.9 mmol) was dissolved in dry methylene
chloride (77 mL)

then was transferred to a 3-neck 1 L flask under Ar

atmosphere. The flask was cooled at -78 °C until the internal temperature
became at least -72 °C. Trimethylaluminum 25% in Hexanes (7.08 mL, 17.71
mmol) was added via cannula as a continuous stream over 15 minutes. The
acetone/ dry ice bath was removed, and the reaction was allowed to warm to 25
ºC then stirring was continued for at least 2 hours. The mixture is added to a
separatory funnel and washed with deionized water. Methylene chloride was
removed via spin-evaporation and the remaining aqueous mixture was extracted
with toluene (150 mL). The wet toluene layer was filtered through a celite pad to
provide filtrate with an assumed quantitative yield of triethyl((1R,2S)-2-methyl-5(phenylthio)cyclohepta-3,5-dienyloxy)silane (2.67 g, 7.70 mmol, 100 % yield).
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The crude filtrate was subjected to the Noyori oxidation without further
purification.

A

solution

of

crude

triethyl((1R,2S)-2-methyl-5-

(phenylthio)cyclohepta-3,5-dienyloxy)silane (2.670 g, 7.70 mmol) in toluene,
(35.0 mL) is stirred under air to give a brown solution. Sequential addition of
sodium tungstate dihydrate (0.154 mL, 0.154 mmol), phenylphosphonic acid
(0.154 mL, 0.154 mmol), methyltrioctylammonium hydrogen sulfate (0.308 mL,
0.154 mmol), and hydrogen peroxide 30% (1.57 mL, 15.4 mmol), was followed
by vigorous stirring at 25 °C. After 4 hr the reaction was judged complete by TLC
and the mixture was transferred to a separatory funnel, brine (200 mL) was
added. The aqueous layer was extracted with ether (2×100 mL) and the
combined organic layers were washed with saturated Na2SO3 solution, dried over
Na2SO4 and concentrated via rotary evaporation to give triethyl((1R,2S)-2methyl-5-(phenylsulfonyl)cyclohepta-3,5-dienyloxy)silane (2.79 g, 7.4 mmol, 96
% yield) as an orange oil TLC (50% ethyl acetate/hexanes) Rf 0.39. 1H NMR
(600 MHz, Chloroform-d)  7.85 – 7.82 (m, 2H), 7.60 – 7.56 (m, 1H), 7.51 (dd, J
= 8.4, 7.1 Hz, 2H), 7.11 – 7.04 (m, 1H), 6.00 (d, J = 11.8 Hz, 1H), 5.91 (dd, J =
11.8, 6.5 Hz, 1H), 4.08 – 4.01 (m, 1H), 2.71 – 2.55 (m, 2H), 2.43 (ddd, J = 14.7,
7.2, 3.6 Hz, 1H), 0.96 (d, J = 7.1 Hz, 3H), 0.91 (t, J = 8.0 Hz, 9H), 0.55 (q, J = 7.9
Hz, 6H). This material was used in the next step without further purification.
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A

solution

of

triethyl((1R,2S)-2-methyl-5-

(phenylsulfonyl)cyclohepta-3,5-dienyloxy)silane (0.106 g, 0.280 mmol) and urea
hydrogen peroxide (UHP) (0.100 g, 1.021 mmol) in DCM : MeOH (0.470 mL:
0.466 mL) in the presence of ammonium acetate (4.31 mg, 0.056 mmol) and
(S,S)-(+)-N,N'-bis(3,5-di-tert-butylsalicylidene)-1,2cyclohexanediaminomanganese(III) chloride (8.88 mg, 0.014 mmol) at 0 °C. After
completion of the reaction, catalyst was destroyed at room temp with hydrogen
peroxide, turning the reaction mixture from dark brown to golden yellow, the
method was spun off and the aqueous-layer was diluted with methylene chloride:
hexanes 1:10 and the mixture was stirred and the layer allowed to settle. The
catalyst was separated from the epoxide by precipitating it with hexane.
Enantiomeric excess for the product epoxide was determined NMR integration.
1

H NMR (600 MHz, Chloroform-d)  7.85 (dd, J = 7.6, 1.5 Hz, 2H), 7.63 – 7.57

(m, 1H), 7.52 (t, J = 7.7 Hz, 2H), 7.15 (dd, J = 3.8, 1.8 Hz, 1H), 4.64 (dd, J =
10.0, 3.7 Hz, 1H), 3.96 (dt, J = 6.2, 2.1 Hz, 1H), 2.58 (dddt, J = 13.6, 11.9, 2.8,
1.6 Hz, 1H), 2.22 – 2.14 (m, 1H), 1.77 (dtd, J = 16.5, 6.9, 2.0 Hz, 1H), 1.64 (dtd, J
= 13.9, 6.7, 1.9 Hz, 1H), 1.31 (ddt, J = 14.4, 12.0, 2.4 Hz, 1H), 1.03 (d, J = 6.9
Hz, 3H), 0.90 (t, J = 8.0 Hz, 9H), 0.55 (q, J = 8.0 Hz, 6H).
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To a fire-dried 5 mL 3-neck round-bottom flask under argon
was

added

(1R,5S,6S,7S)-6-(tert-butyldimethylsilyloxy)-5,7-dimethyl-4-

(phenylsulfonyl)cyclohept-3-enol

(50

mg,

0.122

mmol)

and

2,2'-

Azobisisobutyronitrile (1.000 mg, 6.09 µmol). The solids were dissolved in
Carbon tetrachloride (1.218 mL) with stirring and the reaction was heated to 50
°C. The reaction was monitored by TLC (2:1 Hexanes: Ethyl Acetate; panisaldehyde-UV/vis) and when no remaining starting material was observed, the
reaction was quenched with saturated sodium thiosulfate solution, the organic
layer dried over sodium sulfate, and the solvent removed via rotary evaporation.
The crude product was purified by silica gel flash chromatography, 3:1 hexanes:
ethyl acetate, and the product was dried under high vacuum to yield
(1S,2S,5S,6S,7S)-2-bromo-6-(tert-butyldimethylsilyloxy)-5,7-dimethyl-4(phenylsulfonyl)cyclohept-3-enol (15 mg, 0.031 mmol, 25.2 % yield). 1H NMR
(600 MHz, Chloroform-d)  7.87 – 7.82 (m, 2H), 7.64 – 7.58 (m, 1H), 7.54 (dd, J
= 8.5, 7.1 Hz, 2H), 7.22 (d, J = 6.9 Hz, 1H), 5.04 (s, 1H), 3.93 (d, J = 9.5 Hz, 1H),
3.64 (d, J = 41.3 Hz, 1H), 2.52 (qd, J = 7.4, 3.0 Hz, 1H), 1.53 (d, J = 3.1 Hz, 1H),
1.31 – 1.24 (m, 3H), 1.24 – 1.13 (m, 3H), 0.75 (s, 9H), -0.20 (s, 3H), -0.43 (s,
3H).
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2-bromo-2-methylpropanoic acid (10 g, 59.9 mmol) and sodium
azide (5.84 g, 90 mmol) were mixed in dry dimethylformamide (DMF) (130 mL)
and stirred at 20 °C. The reaction was monitored after 2 days, then partitioned
between 5% LiCl solution (2  1L), Washed with 0.1 M HCl solution (2  1L) ,
then brine, dried over MgSO4, filtered, spin-evaporated and dried to constant
weight (3.212 g, 0.91 mmol, 55 % yield)

under hi-vac. 1H NMR (600 MHz,

Chloroform-d)  11.12 (s, 1H), 1.52 (s, 6H).

triethyl(((1S,2S,3R,7S)-2-methyl-6-(phenylsulfonyl)-8oxabicyclo[5.1.0]oct-5-en-3-yl)oxy)silane (1.205 g, 3.05 mmol)

was stirred in

MeOH (30.5 mL) cooled to 0 °C with an ice bath. Powdered sodium borohydride
(0.127 g, 3.36 mmol) was added and the ice bath removed. After 20 min H2O
was carefully added and the methanol was removed wide rotary evaporation.
The remaining aqueous layer was extracted with dichloromethane (2 x 50 mL).
The crude mixture was purified by flash chromatography. 1H NMR (600 MHz,
Chloroform-d)  7.87 – 7.84 (m, 2H), 7.62 – 7.57 (m, 1H), 7.52 (t, J = 7.7 Hz, 2H),
7.15 (dd, J = 3.8, 1.8 Hz, 1H), 4.68 – 4.61 (m, 1H), 3.96 (dt, J = 6.3, 2.1 Hz, 1H),
2.58 (ddq, J = 15.2, 11.7, 1.7 Hz, 1H), 2.22 – 2.14 (m, 1H), 1.82 – 1.72 (m, 1H),
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1.68 – 1.58 (m, 1H), 1.31 (ddt, J = 14.1, 11.9, 2.2 Hz, 1H), 1.03 (d, J = 7.0 Hz,
3H), 0.90 (t, J = 8.0 Hz, 9H), 0.54 (q, J = 7.9 Hz, 6H).

Oxalyl chloride (0.212 mL, 2.420 mmol) was added at 0
°C to a solution of 2-azido-2-methylpropanoic acid (0.391 g, 3.03 mmol), DMF
(0.023 mL, 0.303 mmol) in PhCH3, (10 mL). The mixture was stirred for 1 h at 25
°C. In a separate reaction vessel dimethylaminopyridine DMAP (0.037 g, 0.303
mmol) was added to a solution of triethylamine (TEA) (0.84 mL, 6.05 mmol) and
alcohol

(1S,6R,7S)-7-methyl-3-(phenylsulfonyl)-6-((triethylsilyl)oxy)cyclohept-2-

enol (0.400 g, 1.009 mmol) in methylene chloride (10.00 mL) at 25 °C. The
alcohol solution was then transferred to the acid chloride solution at 0 °C and the
mixture was stirred for 1 hr at 0 °C. Phosphate buffer (3 mL, 0.05 M, pH = 7) was
added and the aqueous layer was extracted with EtOAc (3 x 3 mL). The
combined organic extracts were washed with brine (3 mL), dried (Na2SO4),
filtered, the solvent was removed under reduced pressure, and purified by
column

chromatography

(SiO2,

5-10%

EtOAc/hexanes)

to

furnish

the

(1S,6R,7S)-7-methyl-3-(phenylsulfonyl)-6-((triethylsilyl)oxy)cyclohept-2-en-1-yl 2azido-2-methylpropanoate (0.461 g, 0.91 mmol, 90 % yield) as a yellow oil. 1H
NMR (600 MHz, Chloroform-d)  7.86 – 7.83 (m, 2H), 7.64 – 7.60 (m, 1H), 7.54
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(t, J = 7.7 Hz, 2H), 6.98 – 6.94 (m, 1H), 5.80 (dd, J = 10.1, 4.1 Hz, 1H), 4.00 (dt,
J = 6.5, 2.1 Hz, 1H), 2.67 – 2.58 (m, 1H), 2.22 – 2.14 (m, 1H), 2.03 (dtd, J = 16.3,
6.8, 1.9 Hz, 1H), 1.75 – 1.66 (m, 1H), 1.50 (d, J = 7.2 Hz, 6H), 0.97 (d, J = 6.9
Hz, 3H), 0.91 (t, J = 7.9 Hz, 9H), 0.56 (q, J = 7.9 Hz, 6H).

A dry 250 mL round-bottomed flask was charged with a
solution of (1S,6R,7S)-7-methyl-3-(phenylsulfonyl)-6-((triethylsilyl)oxy)cyclohept2-en-1-yl 2-azido-2-methylpropanoate (0.626 g, 1.23 mmol) in methylene chloride
(12.3 mL) then the solution was cooled to 0 °C, then (1R,4R)-7,7-dimethyl-2oxobicyclo[2.2.1]heptane-1-sulfonic acid (0.32 g, 1.48 mmol) was added. After 24
hours the reaction was not completely done so additional (1R,4R)-7,7-dimethyl-2oxobicyclo[2.2.1]heptane-1-sulfonic acid (0.323 g, 1.480 mmol) was added and
the reaction was monitored by TLC (35% EtOAc: Hexanes; UV/ PAA vis) there
was starting material left, so an additional aliquant of (1R,4R)-7,7-dimethyl-2oxobicyclo[2.2.1]heptane-1-sulfonic acid (0.323 g, 1.480 mmol) was added TLC
monitoring (see above) showed. The reaction mixture was washed with sodium
bicarbonate solution, deionized water, and brine. The isolated organic layer was
dried over sodium sulfate clarified by gravity filtration, spin-evaporated down to
oil, and dried to constant weight under hi vac. The crude oil was partitioned
between acetonitrile and hexanes to remove the silicon oil from the desired
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product. The acetonitrile layer was isolated and washed twice more with an equal
volume of hexanes. 1H NMR (600 MHz, Chloroform-d)  7.86 – 7.82 (m, 2H),
7.64 – 7.60 (m, 1H), 7.54 (t, J = 7.7 Hz, 2H), 6.97 (dd, J = 4.1, 1.4 Hz, 1H), 5.77
(dd, J = 10.0, 4.2 Hz, 1H), 4.03 (dt, J = 6.6, 2.5 Hz, 1H), 2.62 (ddd, J = 16.0,
11.4, 2.0 Hz, 1H), 2.21 (ddd, J = 16.0, 7.7, 2.2 Hz, 1H), 2.16 (s, 1H), 2.14 (s, 1H),
1.80 – 1.74 (m, 1H), 1.60 – 1.54 (m, 1H), 1.49 (d, J = 3.2 Hz, 6H), 1.03 (d, J = 7.0
Hz, 3H).

To a stirred clear colorless solution of (1S,6R,7R)6-hydroxy-7-methyl-3-(phenylsulfonyl)cyclohept-2-en-1-yl-2-azido-2methylpropanoate (1.0525 g, 2.68 mmol) in methylene chloride (15 ml) and
methanol (3.75 ml) was added sodium bicarbonate (2.25 g, 0.03 mol) followed by
cooling to -78 °C and bubbling of

ozone for 15 min followed by addition of

dimethyl sulfide (2.0 ml, 0.03 mol). The above mixture was stirred at room
temperature for 4 hr then quenched by addition of 5% HCl (12 mL). The
quenched reaction mixture was transferred to a separatory funnel and extracted
with Et2O (2 × 20 mL). The combined organic extracts were washed with brine
(20 mL), dried over Na2SO4 and concentrated by rotary evaporation to give a
colorless oil. The crude oil was purified by flash column chromatography
(Hexanes:EtOAc = 1:1) to give (3S,4R,5R)-2-hydroxy-5-(3-methoxy-3-oxopropyl)-
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4-methyltetrahydrofuran-3-yl 2-azido-2-methylpropanoate (0.700 g, 2.220 mmol,
83 % yield) as a colorless oil.

To

a

solution

of

(1S,6R,7R)-6-hydroxy-7-methyl-3-

(phenylsulfonyl)cyclohept-2-en-1-yl 2-azido-2-methylpropanoate (0.133 g, 0.338
mmol) in 1:1 BuOH (2.414 mL) : water (2.414 mL) was added Nmethylmorpholine-N-oxide (NMO) (0.087 g, 0.744 mmol) (50% wt in H2O, 2 eq),
citric acid (0.016 g, 0.085 mmol), and osmium tetroxide (0.085 mL, 6.76 µmol).
After 24 h, The TLC (1:1; Hex:EtOAC) indicated disappearance of starting
material so the reaction mixture was quenched with saturated aqueous Na2S2O3
and stirred for 30 min. The aqueous layer was separated and extracted with
Et2O. The combined organic layers were dried over MgSO4, filtered, and
concentrated

to

furnish

(1S,3S,4R,5R)-1,2-dihydroxy-4-methyl-8-

oxabicyclo[3.2.1]octan-3-yl 2-azido-2-methylpropanoate (80 mg, 0.280 mmol, 83
% yield) as a clear resin. 1H NMR (600 MHz, Chloroform-d)  5.20 (dt, J = 5.2,
1.2 Hz, 1H), 4.19 (d, J = 8.1 Hz, 1H), 3.99 (dd, J = 5.3, 2.0 Hz, 1H), 2.65 – 2.57
(m, 1H), 2.30 (tdd, J = 12.9, 8.1, 4.8 Hz, 1H), 2.02 – 1.94 (m, 1H), 1.88 (q, J = 7.2
Hz, 1H), 1.61 (tdd, J = 13.1, 4.8, 2.2 Hz, 1H), 1.54 (d, J = 4.3 Hz, 5H), 1.43 (d, J
= 5.9 Hz, 1H), 1.28 (dd, J = 4.1, 3.0 Hz, 2H), 1.23 (d, J = 7.5 Hz, 3H).
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To a stirred solution of the (1S,3S,4R,5R)-1,2-dihydroxy-4methyl-8-oxabicyclo[3.2.1]octan-3-yl 2-azido-2-methylpropanoate (0.020 g, 0.070
mmol) in 1:2 MeOH (0.467 mL) and benzene (0.935 mL) was added lead
tetraacetate (0.042 g, 0.095 mmol) in portions over a period of 30 min at room
temperature. After the mixture stirred for the required time, dilute NaHCO3 was
added and extracted with ethyl acetate. The combined organic layer was washed
once with brine and dried over anhydrous Na2SO4. Concentration followed by
silica gel chromatography of the crude yielded (2S,3R)-1-oxo-3-((R)-5oxotetrahydrofuran-2-yl)butan-2-yl 2-azido-2-methylpropanoate (17 mg, 0.060
mmol, 86 % yield).1H NMR (600 MHz, Chloroform-d)  9.56 (d, J = 1.1 Hz, 1H),
5.51 (t, J = 1.7 Hz, 1H), 4.42 (td, J = 9.2, 6.4 Hz, 1H), 2.65 (ddd, J = 10.1, 5.9,
1.7 Hz, 3H, 1.61 (d, J = 1.2 Hz, 3H), 1.57 (s, 3H), 1.11 (dd, J = 7.0, 1.9 Hz, 1H),
1.04 (dd, J = 7.0, 1.1 Hz, 3H).
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ABSTRACT

Cyclic asymmetric vinylsulfones and vinyphosphonates have been used towards the synthesis of aplyronine A and
discodermolide respectively. Oxidative cleavage of these highly deactivated olefins to furnish linear fragments has
been accomplished under harsh ozonolysis conditions. Osmylation of these substrates can now be accomplished
with the addition of citric acid. The resulting acyloins and lactols can be smoothly cleaved with lead tetraacetate.

Catalytic osmylation of olefins is a well-established
protocol developed by chemists at Upjohn.1 While the
Sharpless’ group has provided the state-of-the-art
osmylation in organic synthesis.2345 Highly electron

deficient olefins proved to be unreactive to traditional
osmium catalyzed dihydroxylation procedures. Due to the
mildness and general application of osmylation
methodology, it is greatly preferred over ozonolysis.

1
V. Vanrheenen, R. C. Kelly, and D. Y. Cha Tetrahedron Lett. 1976,
1973-76.
2
S. G. Hentges and K. B. Sharpless J. Am. Chem. Soc. 1980, 102,
4263-65.
3
E. N. Jacobsen et al. J. Am. Chem. Soc. 1988, 110, 1968-70.

4
C. J. Burns, C. A. Martin, and K. B. Sharpless J. Org. Chem. 1989,
54, 2826-34.
5
J. S. M. Wai et al. J. Am. Chem. Soc. 1989, 111, 1123-25.
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Use of cyclic asymmetric vinylsulfones has formed the
backbone of a polypropionate strategy developed by the
Fuchs group.6 This methodology has been used for the
successful synthesis of L-(-)-prostaglandin E2,78 dlmorphine,91011 and 19-nor-Vitamin D-3.12 This
methodology has been used to generate the dipropionate
fragments C5-C12, C21-C27 and des-methyl C28-C34 of
aplyronine A.131415 This investigation examines the effects
of citric acid buffered osmium catalyzed dihydroxylation
on cyclic vinylsulfones and vinyphosphonates.

electron-deficient alkenes. In addition to acting as a pH
buffer thereby preventing formation of insoluble Os(VIII)
dioxoosmate iv, a species, that inhibits the second cycle,
citric acid strongly binds to OsO4 and maintains the
reaction in the second cycle.18

Figure 1. Caption

Figure 2. Citric Acid Catalyzed cis-Dihydroxyltion of
Vinylsulfones

The proposed mechanism of osmium tetroxide (OsO4)
dihydroxylation (Figure 1) suggested that the rate is
sacrificed if (mono)glycosylate ii is hydrolyzed to
regenerate diol and osmium tetroxide perpetuating the
First Cycle.16 The Second Cycle is favored over the First
Cycle all things being equal. Since the rate of hydrolysis
(h1) is much slower than the reduction (r3), the
osmium(VI) bis(glycolate) iii builds up as the reaction
progresses, generating diol via hydrolysis of
(bis)glycolate iii. To exploit the Second Cycle when using
chiral ligand, a slow addition technique was
recommended to suppress the second cycle pathway
during asymmetric dihydroxylation (AD).17 However, if
high reactivity is required, the second cycle gives a clear
advantage over the first cycle. Citric acid improves the
rates and the yields of cis-dihydroxylations of various
6

A. El-Awa et al. Chem. Rev. 2009, 109, 2315-49.
7
R. E. Donaldson and P. L. Fuchs J. Am. Chem. Soc. 1981, 103,
2108-10.
8
R. E. Donaldson et al. J. Org. Chem. 1983, 48, 2167-88.
9
J. E. Toth and P. L. Fuchs J. Org. Chem. 1987, 52, 473-75.
10
J. E. Toth, P. R. Hamann, and P. L. Fuchs J. Org. Chem. 1988, 53,
4694-708.
11
——— J. Org. Chem. 1988, 53, 4694-708.
12
V. Sikervar, J. C. Fleet, and P. L. Fuchs Chem. Commun. 2012, 48,
9077-79.
13
A. El-Awa, X. M. du Jourdin, and P. L. Fuchs J. Am. Chem. Soc.
2007, 129, 9086-93.
14
M. N. Noshi, A. El-Awa, and P. L. Fuchs J. Org. Chem. 2008, 73,
3274-77.
15
W. P. Hong et al. Org. Lett. 2011, 13, 6342-45.
16
Wai et al.
17
Ibid.
18

Addition of citric acid to improve the catalytic
asymmetric osmylation system led to a greater
understanding of the catalytic cycle that the vinylsulfone
substrate undergoes (Figure 2). During the course of
Sharpless’ investigation to improve upon the Upjohn
protocol, it was found that the osmylation catalytic cycle
can, as previously stated, progress via two alternate
avenues where the rate limiting step is hydrolysis of the
monoglycolate (i) in the case of the first cycle and
bisglycolate (ii) in the case of the faster second cycle
Figure 2. When the osmylation is undertaken in
homogeneous
conditions
the
co-oxidant
Nmethylmorpholine N-oxide (NMO) has access to the
intermediates over the entire catalytic cycle. Since the
Second Cycle is faster, with the addition of citric acid,
the reaction gets locked into the second cycle
(bis)glycolate (ii) hydrolysis furnishes Os(VI) species iii.
The Sharpless group postulated that acids assist
catalyst turnover by preventing formation of the
catalytically dormant dioxoosmate dianion species iv,
which is formed upon deprotonation of the hydrated
(bis)glycolate iii at higher pH (Figure 3).
The strong electron withdrawing ability of the
sulfone contributes to the acidity of the hydrated
bis(glycolate) species iii•H2O thus increasing the
concentration of the dioxoosmate iv and crippling the
cycle. The Sharpless group then discovered, based on the

Yun Gao and Young Cheun, "Osmium Tetroxide–NMethylmorpholine N-Oxide," in Encyclopedia of Reagents for Organic
Synthesis (John Wiley & Sons, Ltd, 2001).
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aforementioned hypotheses that the dioxoosmate iv is
especially stable and resistant to substitutions of any kind
under basic conditions including hydrolysis irrespective
of the presence co-oxidant. According to Sharpless, all
acidic mixtures remain green indicating the presence of
neutral bis(glycolate) (ii) whereas basic mixtures took on
a reddish brown color indicating the presence of
dioxoosmate dianion species iv. Adding citric acid
however arrests the formation of osmium tetroxide
(OsO4) in favor of species iii thereby impeding the First
Cycle (Figure 2). With proximal acidic moieties acting
as a buffer in hydrated (bis)glycolate iii•H2O and
dioxoosmate iv the equilibrium leans strongly in favor of
bis(glycolate) ii which can then be hydrolyzed back to
species i so the cycle may continue (Figure 3).

Figure 3. Effect of Citric Acid on Dioxoosmate Formation

It is noteworthy that olefins such as diethyl maleate
show the greatest benefit from performing the
dihydroxylation at lower pH.19 The hydrated osmium(VI)
bis(glycolates) like species iii•H2O formed from such
electron-poor olefins would be expected to be much more
acidic and correspondingly more likely to get trapped as
the unwanted dioxoosmate dianion iv, even in the
presence of a relatively weak base like 4methylmorpholine. Citric acid however not only
coordinates to the osmium, but coordinates the acidic
moieties proximal to the oxygens of the hydrated
(bis)glycolate iii so buildup of dioxoosmate iv will not
terminate the catalytic cycle.
Methodology elucidated by Sharpless,202122 involving
dihydroxylation of election deficient olefins by osmium,
catalyzed by citric acid was explored on stereotriad entry
13. Rationale for the efficacy of the osmium/citric acid
methodology is derived from the proposed catalytic cycle
in Figure 2.
With a solid foundation for osmium catalyzed
dihydroxylation of olefin deficient olefins being in
evidence, investigation of this methodology on advanced
vinylsulfones and vinyphosphonates was undertaken.
19

Philippe Dupau et al. Adv. Synth. Catal. 2002, 344, 421-33.
Ibid.
21
Timothy J. Donohoe et al. J. Org. Chem. 2006, 71, 4481-89.
22
Timothy J Donohoe et al. Angew. Chem. 2008, 120, 2914-17.
20

Table 1. Osmium Catalyzed Dihydroxylation of Vinyl Sulfones
and Phosphonates
Entry

Substrate

Product

Yield

1

100%a

2

79%a

3

100%b

4

NR a,b

5

59%b

6

NRa

7

NRa,b

8

NR b

9

68%b

10

NRa

i-Pr
HO

OTBS

45%b

11
O

OH

12

62%b

13

89%b

a. Conditions: 0.1M, citric acid (20 mol%), NMO (1.5 eq.), K2OsO4 (5
mol %), MeCN: H2O (4:1), 50 ºC, 24 hrs b. Conditions: 0.1M, NMO
(1.5 eq.), K2OsO4 (5 mol %), MeCN: H2O (4:1), 25 ºC, 24 hrs
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The data obtained by the examination represented by
Table 1 indicates that bulky stereotetrads such as those
represented in entries 1 and 2 required heating at 50 °C
to effect dihydroxylation. Entries 3, 5, 9, 12 and 13
however dihydroxylated smoothly at room temperature.
Entry 3 is a bulky vinyphosphonate, and entry 9 is an
unhindered vinyphosphonate. Yields would indicate that
entry 3 is in a more favorable conformation to form the hydroxy lactol than is entry 9. In contrast entry 10
recovered starting material under the stated conditions.
Entry 10 does not however have the possibility of
forming -hydroxy lactol as it is di-protected. Entry 11
also reacted at room temperature but in low yield
probably due to the presence of isopropyl and TBS
moieties. Entries 4, 6, 7, 8, & 10 did not react under the
stated conditions. Entry 4 is a 6-membered ring which
may have less flexibility. Entry has a chloro and TBS
silylether which may contribute negative steric and
electronic effects. Entries 7 & 10 have the added bulk of
2 TBS groups.

Table 2. Pb(IV)OAc Cleavage
Entry

Acyloin/ Lactol

Cleavage Product

Yield

1

100%

2

100%

3

100%

4

100%

5

100%
i-Pr
HO

OTBS

100%

6
O

OH

7

100%

8

89%

a. Conditions: Pb(OAc)4 (1.5 eq.), dry methanol (0.1M), room
temperature, 24 hrs.

All acyloins and -hydroxy lactols underwent
complete conversion to their respective cleavage products
in ~24 hours under the stated conditions (Table 2).
Overall, we have described a general mild oxidative
cleavage
methodology
for
vinylsulfones
and
vinyphosphonates that provides acceptable yields over a
considerable range of diverse substrates. Our preliminary
studies have defined (1) a general methodology for the
osmium catalyzed dihydroxylation of vinylsulfones and
vinyphosphonates, which are valuable intermediates in
the synthesis of polyketide natural products. (2) the
impact of stereochemistry and and steric bulk on the
dihydroxylation process. As such, this method is
anticipated to greatly facilitate the efficient synthesis of
linear complex polyketidederived targets from
vinylsulfone derived polypropionate substrates. Progress
along these lines, will be reported in due course.

